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ABSTRACT
Pre-B cell receptor (pre-BCR) signaling is a critical checkpoint in B cell development
in which B-lineage cells expressing functional µ-chains undergo selective expansion. My
dissertation work used a rabbit model system to study how VH structure affects the early
stages of B cell development in the bone marrow (BM). Developing B cells in mutant
ali/ali rabbits predominantly utilize VH4 during VDJ gene rearrangement. However, most
of the VH4-utilizing B cells encounter a severe block early in B cell development. In
contrast, wildtype rabbit B cells predominantly rearrange VH1, a gene >90% identical to
VH4, and develop normally. I wanted to determine how these nearly identical VH genes
have profoundly different effects on B cell development. We hypothesized that VH4utilizing cells are blocked at the pro- to pre-B cell transition due to defects in pre-BCR
signaling. My studies indicate that VH4-utilizing pre-B cells fail to expand normally and
that VH4-μ chains do not form pre-BCR. These data are consistent with a cell intrinsic
model of VH4-utilizing pre-B cell loss resulting from insufficient pre-BCR signaling.
The pre-BCR is a complex of the μ-chain and a light chain-like molecule called
surrogate light chain (SL). The fact that some VH4-utilizing B cells survive development
in BM and undergo expansion in the periphery suggests that VH4-μ chains in the context
of conventional BCR are functional. This gave me the opportunity to identify amino
acids that are specifically required for pairing with SL but are dispensable for
conventional BCR formation. I used site-directed mutagenesis to mutate residues
xv

differing between VH1 and VH4 that were predicted to interact with (SL); however, none
of the mutations I made were sufficient to restore VH4-μ pre-BCR formation. We
hypothesize that the inability of VH4-μ to pair with SL is due to a combination of residues
encoded by VH and possibly DJH (CDR3). More extensive mutagenesis will be needed to
identify the structural basis for the in ability of VH4-μ to pair with SL.
My studies also identified a possible mechanism by which select VH4-utilizing Blineage cells survive development through expression of conventional IgL during the
early B cell stages. To determine if premature Igκ expression in developing ali/ali B
cells is sufficient to rescue VH4-utilizing B cell development, we used Igκ-transgenic
ali/ali rabbits and found that these rabbits exhibit a 5-fold increase in peripheral VH4utilizing B cells compared to age matched non-transgenic controls. These data suggest
that early expression of IgL and signaling through the conventional BCR is a plausible
mechanism by which VH4-utilizing cells bypass the developmental block at the early preB cell stage.
The ali/ali rabbit has been used for over 25 years to study B cell selection in the BM
and in the periphery. My work identified the stage and mechanism by which VH4utilizing B-lineage cells are lost during development in the BM and suggests a plausible
mechanism by which select VH4-utilizing cells bypass the block at the pre-B cell stage
through early rearrangement and expression of IgL. These studies lay the ground work
for future experiments aimed at identifying the structural parameters encoded by VH
genes that allow for pre-BCR formation and normal pre-B cell expansion.

xvi

CHAPTER ONE
LITERATURE REVIEW
Introduction
Memory B and T cells are central to the adaptive immune response based on their
ability to rapidly identify and respond to previously encountered pathogens. The
adaptive immune response is most easily understood in the context of vaccination.
Vaccines prime adaptive immune cells using weakened forms of pathogens or their toxins
resulting in long lived immunological memory. Subsequent infection by fully virulent
organisms activates memory B and T cells resulting in robust immune responses and
rapid pathogen clearance. The first vaccine was administered by Edward Jenner against
small pox in 1796. Jenner found that infecting healthy patients with the less lethal cow
pox virus yielded lasting protection against small pox [1]. While this may seem logical
based on our current knowledge of vaccine responses, at that time Jenner’s work was
truly cutting edge and many consider him the “Founder of Immunology”. In the next
century, Louis Pasteur repeated Jenner’s experiments using a chicken model for cholera
and found that infecting chickens with killed forms of cholera made them resistant to
subsequent infections with live cholera. Although it was clear that vaccination protected
healthy individuals from getting disease, the mechanism(s) for this protection remained
unknown.
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The mechanism was finally determined in 1890, when Emil von Behring and
Shibasaburo Kitasato discovered the antibody using a guinea pig model of passive
immunity. They found that serum from animals immunized with diphtheria toxin (DT)
protected naïve animals from lethal doses of DT but was not protective against tetanus
toxin [2]. These studies initiated the concept of adaptive immunity, in which the immune
system could be “educated” to specifically recognize particular pathogens. The study of
anti-toxin responses by Behring and Kitasato led to the initial classification of antibodies
as “antitoxins.” At a similar time, Paul Ehrlich used a rabbit model system to develop
his “side-chain” hypothesis of antibody responses, which proposed that anti-toxin acted
as a decoy toxin receptor that would absorb toxins and prevent their binding to target
cells. The term “magic bullet”, used now to describe monoclonal antibodies, was
originally coined by Ehrlich who thought that these “side chains” could be designed to
recognize specific toxins [2].
Since that time, numerous studies have focused on the functional properties and origin
of antibody responses. The first protein sequence of an antibody molecule was generated
in 1969 by Gerald Edelman and demonstrated at the amino acid level that antibodies had
constant and variable regions. Based on the amino acid sequence and protein digests,
Edelman began making models of Ig structure and proposed that the antigen binding
domain was comprised of both IgH and IgL chains [3]. The crystal structure of Ig was
initially solved in pieces between the late 1960’s through the early 1990’s. The Igλ
constant region was the first Ig structure solved at high resolution [4]. Soon after, the
crystal structures of the antigen binding domain [5] and IgG constant regions [6] were
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determined, and these data were combined to form a composite antibody structure. It was
not until 1992 [7] that a completely intact IgG structure was solved, and it looked
remarkably similar to the IgG structure proposed by Edelman almost 25 years earlier
(Fig. 1).
The adaptive immune system is randomly generated and provides a diverse arsenal of
B and T lymphocytes that respond to stimulation by their cognate antigens. Antibody
diversity is generated by developmentally controlled mechanisms involving multiple
environmental cues. During B cell development in BM, rearrangement of Ig genes
results in novel exons that encode the antigen binding domain and dictate antibody
specificity. The initial antibody repertoire is generated independently of antigen. In the
periphery activated B cells encounter their cognate pathogen and participate in an antigen
driven process called affinity maturation. Affinity maturation introduces site-directed
mutations in the Ig genes encoding the antigen binding domain and alters antibody
specificity. B cell clones that achieve higher affinity for their antigen are positively
selected whereas those that lose affinity are deleted. The affinity maturation process can
increase antibody affinity by orders of magnitude with some antibodies having a KD of
<10-9 M.
Antibody mediated immune responses have been evolving for more than 450 million
years. In many cases, B cell responses generate immunological memory, which allows
for faster and more robust antibody responses should the host re-encounter the same
pathogen. These memory responses have been utilized for the purposes of vaccination
which help control and, in some cases, eradicate disease (e.g. polio, tetanus, influenza,
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measles, mumps, rubella, small pox and hepatitis B). More recent research has led to the
development of in vitro generated “designer antibodies” that can be used to treat cancer,
autoimmune disease, and possibly allow for passive immunity against diseases for which
human vaccination is difficult or not possible.
Evolution of the Antibody Response
The rise of antibody mediated immunity dates back ~500 million years as evidenced
by the presence of functional Ig gene loci in cartilaginous fish (Fig. 2) [8, 9]. Just prior to
the development of antibody mediated immunity, jawless fish (lamprey and hagfish)
began evolving their own type of adaptive immunity that was just discovered in the last
decade [10]. The effector proteins used by lamprey are called variable lymphocyte
receptors (VLR) and diversity is generated similarly to antibodies through somatic
rearrangement of VLR genes. VLRs are “antibody like” in function but bear no
structural resemblance to Ig (Fig. 3) [11], marking an excellent example of convergent
evolution where two species initiated different strategies to solve the same problem.
The most sophisticated antibody producing species are mammalian with 5 antibody
isotypes in mouse and human (IgM, IgD, IgG, IgA, IgE), most of which have known
functions. Isotypes are encoded by the constant region Ig genes and affect antibody
function but not specificity. Not all antibody producing species express all 5 isotypes, as
many were acquired over the course of evolution; however, all of these species have IgM,
which is the membrane bound isotype expressed during B cell development [12]. Upon
B cell activation in the periphery, the membrane bound form becomes a secreted and
often multimeric form to help clear pathogens from the blood and lymph. The IgD
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isotype (IgW in some fish species) is generated by alternative splicing of the μ-transcript,
and while IgD is abundantly expressed on mature B lymphocytes in mouse and human,
the function(s) of IgD are not completely understood. Recent studies have implicated
IgD in priming inflammatory responses [13]; however, in some cases (e.g. birds and
rabbits), the IgD encoding gene is either absent or no longer functional, indicating that it
is not essential to antibody mediated immunity in these species.
Immunological memory and affinity maturation coincide with emergence of
amphibians and the IgY isotype (~350 million years ago). The presence of IgY (ancestral
gene for IgG and IgE isotypes) in amphibians and IgG in other species is important for
pathogen neutralization and clearance. The IgE isotype in humans is important for
protection against parasites; however, in developed countries, IgE responses are typically
associated with allergy and asthma due to increased responses to innocuous antigens.
IgA is the most abundant antibody in human and mouse but is largely confined to
mucosal tissues and mother’s milk, with only limited concentrations in the serum. The
IgA isotype has only been identified as far back as reptiles; however, some amphibian
species encode a mucosal associated antibody, IgX, that performs similar functions to
IgA [14]. The major function of IgA is to protect against mucosal pathogens and to
maintain homeostasis in the gut by controlling the types and quantity of commensal
bacteria in the intestines.
Evolution of the adaptive immune response has been studied in many species for more
than 200 years. Much of the work on mammalian antibody responses has used mouse
and rabbit model systems, which use different mechanisms to develop the primary or pre-
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immune antibody repertoire. In mouse and human, the diversity of the pre-immune
repertoire arises from random rearrangement of Ig genes that encode the variable region
[15]; whereas in rabbits, the primary antibody repertoire is generated in two stages. The
first stage of rabbit B cell development occurs in the BM similar to that of mouse and
human; however, variable Ig gene usage in rabbits is highly restricted, resulting in an
initially limited B cell repertoire [16]. The second stage of development occurs in the gut
associated lymphoid tissue (GALT), which in rabbit is largely comprised of the appendix,
where the initially narrow B cell repertoire becomes broader through mechanisms that
will be described later in this review. The following sections focus on mechanisms of B
cell development and antibody diversification as they occur in BM and the periphery with
an emphasis on the early stages of B cell development.
Technology That Revolutionized the Study of Immunology and B cell Development
Generation of Knockout and Transgenic Mouse Strains
Although B cell development has been studied in several species, it was the generation
of knockout and transgenic mouse lines that allowed scientists to determine the specific
function of genes in vivo. In cases where gene ablation is detrimental to embryonic
development, the Cre-lox system can be used to delete genes in select cell types [17, 18].
In this system, the Cre DNA recombinase recognizes DNA stretches called loxP sites and
catalyzes site-specific recombination resulting in DNA excision between the loxP sites.
Flanking a gene of interest with loxP does not interfere with gene expression and function
but expressing the Cre recombinase using an inducible or cell specific promoter allows
the investigator to control gene ablation in a time and/or cell specific manner, even for
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genes required during embryonic development. Current collaborative studies between
North America and Europe are attempting to generate embryonic stem cell knockout lines
encompassing all 20,000 genes in the mouse genome [19]. Currently, 17,000 genes have
been ablated in embryonic stem cell lines and approximately 1,000 knockout mouse
strains have been generated.
Monoclonal Antibodies and Their Classification by Clusters of Differentiation (CD)
Each antigen has multiple epitopes that can be targeted during an immune response.
Therefore, immunization results in activation of multiple B cells each with different
epitope specificity. The resulting antibody (Ab) in the serum is a mixture of B cell clones
and is termed “polyclonal antibody”. Polyclonal antibodies are extremely useful for
many experimental techniques; however, the drawbacks are that each laboratory
generates their own source and the supply of antibody is limited by the size and lifespan
of the animals immunized. These problems of both heterogeneity and limited supply of
polyclonal Ab were solved by Georges Köhler and César Milstein who developed
monoclonal antibodies (mAb) [20]. The cells that secrete mAb are called hybridomas
which are fusions of myeloma cell lines (transformed antibody secreting cells) and
splenic B cells of immunized animals. The myeloma cells maintain their high level
secretory capacity but do not express their own Ig genes; instead, the antigen specific Ig
genes from splenic B cells are expressed. Single hybridomas are clonally expanded and
supernatant from these cultures is tested for antigen recognition. The advantage of this
system is that once antigen specific hybridomas are identified there is a theoretically
endless supply of mAb with known specificity. MAbs are used extensively by scientists
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and more recently have been approved for therapeutic use. Ehrlich pictured his “magic
bullets” as being protective against bacterial toxins, but in fact, most monoclonal
antibodies today are used to treat inflammatory diseases. The first attempt to make
hybridomas was by Schwaber and Cohen in1973 through fusing mouse and human cells
[21]. Köhler and Milstein refined the technique to generate stable clones with single
specificity and were awarded the Nobel Prize in Medicine in 1984.
Early on, hybridomas were generated and shared between laboratories, and with time,
it became evident that a system was needed to organize mAbs. In 1982, the first
conference to establish a nomenclature for mAb was held in Paris, France [22]. At this
meeting, it was decided that mAbs would be categorized by clusters of differentiation
(CD). In order for a cellular molecule to be given a CD number, it had to be recognized
by at least two independent mAbs. Many of these molecules also have common names in
addition to CD designations (e.g. Igα = CD79a). There are currently >300 defined CD
antigens, many of which are used in parallel to discriminate between stages of cellular
development and cell lineage.
The Dawn of Flow Cytometry
The flow cytometer revolutionized the study of cell populations by using fluorescently
labeled antibodies and an automated machine that collects data from thousands of cells
per second. This allowed researchers to acquire large and unbiased data sets while
simultaneously sorting specific cell populations by phenotype for further
experimentation (e.g. isolation of a pure population of precursor cells that can be
differentiated in vitro, or reintroduced into a new host for in vivo studies) [23]. Flow
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cytometry has been instrumental in the precise characterization of B cell development
that continues to be refined today.
B cell Development as it Occurs in the Mouse
Ig Gene Rearrangement and Expression
Generation of the pre-immune antibody/B cell repertoire occurs through random
rearrangement of Ig genes during B cell development. The IgH locus contains V
(variable), D (diversity), and J (Joining) genes whereas IgL loci (κ/λ) have only V and J
gene segments (Fig. 4)[24-27]. These segments are separated in the genome by up to >90
kb; however, during Ig gene rearrangement the V, (D), and J gene segments become
juxtaposed to form new exons that encode the variable regions of Ig chains [28, 29]. Ig
gene rearrangement is a highly ordered process that involves multiple enzymes
recognizing specific DNA sequences flanking the V, D, and J gene segments termed
recombination signal sequences [30] [31]. RSS guide the ordered recombination of Ig
genes using the 12/23bp rule which states that during recombination, gene segments with
a 12bp RSS can only recombine with gene segments flanked by a 23bp RSS (Fig. 5).
The VH and JH gene segments are flanked by an RSS with a 23 bp spacer and the DH
gene segments are flanked on both sides by RSS with 12 bp spacers. Therefore, IgH gene
rearrangement must include the DH region since VH and JH are incompatible for direct
rearrangement. DH and JH rearrange first followed by VH-DJH, and during this process,
the intervening DNA between DJH and VDH is deleted, and as a result, only a single VH
gene can rearrange to DJH due to the deletion of intervening DH genes segments (Fig. 6)
[32]. The V and J genes of the IgL loci also follow the 12-23 bp rule resulting in
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deletion of intervening DNA between VL and JL; however, if downstream JL genes
remain, secondary rearrangements with upstream VH genes can occur at the IgL locus
yielding new specificities (Fig. 7). This process is called receptor editing and is a
mechanism that limits autoreactivity generated by the random nature of V(D)J gene
rearrangement [33].
There are exceptions to the 12/23 bp rule as demonstrated by Koralov et al. who
reported that direct VH to JH rearrangement can occur in vivo in DH deficient mice [34].
This process allows for generation of functional B cells but is much less efficient than the
classical VDJH rearrangement. Additionally, knock-in mice with two out-of-frame VDJ
gene rearrangements are able to undergo VH gene replacement using cryptic RSS
presenting the 3’ end of VH [35]. These sites allow for an upstream VH gene to
recombine and replace the out-of-frame VDJH. These two studies indicate that it is
possible to bypass the 12/23 bp rule but these are exceptions that are likely infrequent
during normal B cell development.
Although all cells contain Ig loci, only B lineage cells fully rearrange their Ig genes
due to controlled expression of the Rag (recombination activation gene) enzymes that
catalyze Ig gene rearrangement. Together, Rag1 and Rag 2 (Rag1/2) recognize the 12/23
RSS and mediate double stranded breaks that are regulated by DNA repair enzymes [36].
V(D)J gene rearrangement results in random nucleotide deletion through asymmetric
hair-pin formation and cleavage by Rag1/2 [15]. Additional non-templated nucleotides
can also be added to the VDH and DJH junctions by an enzyme called terminal
deoxynucleotidyl transferase (TdT) [37]. Asymmetric cleavage and random nucleotide
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additions increase the diversity of the B cell repertoire but can also alter the reading
frame of the V(D)J exons, and consequently, two-thirds of VDJ gene rearrangements are
non-functional [38].
The order of Ig gene recombination was discovered by studying the nature and
frequency of V(D)J gene rearrangements in transformed B-lineage precursors from
mouse fetal liver and mature B cell/plasma cell lymphomas [39]. Most precursors from
fetal liver had DJH rearranged on both alleles but lacked V-DH rearrangements, whereas
mature B cell/plasma cell lymphomas had VDJH rearranged on at least one allele with
DJH or a non-productive VDJH rearrangement on the other allele [39]. Later studies
showed that DJH rearrangement occurs prior to B-lineage commitment as DJH
rearrangements are observed in common lymphoid progenitors and many T lineage cells
[40-42]. B lineage commitment is marked by VH to DJH rearrangement, and functional
VDJH rearrangements encode μ-chains that must pair with a IgL-like complex designated
surrogate light chain (SL) forming the pre-BCR [43-45]. The pre-BCR transmits signals
for proliferation and maturation that redirect the recombination machinery to the IgL loci
for VL and JL rearrangement [46, 47]. Successful rearrangement of IgL and formation of
the conventional B cell receptor (BCR) generates low level survival signaling (called
tonic signaling) which downregulates Rag1/2 expression and terminates Ig gene
rearrangement during B cell development [48-50].
Allelic Exclusion
If all of the Ig loci in B cells were productively rearranged and expressed, there would
be two IgH chains and four IgL chains that would yield a combination of 30 possible
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specificities per B cell. This would be problematic because cells would encode Ig that
was specific to multiple antigens, which would increase the likelihood of autoreactivity.
Alternatively, insufficient expression and crosslinking of an antigen specific BCR would
impede B cell immune responses [51]. Fortunately, each B cell only generates Ig with a
single specificity resulting from expression of a single IgH and IgL. Suppression of the
other Ig loci in the presence of functional BCR is termed allelic exclusion and is
coordinated through Rag1/2 expression and chromatin remodeling.
There are two critical time points where allelic exclusion is initiated and maintained.
First, during IgH rearrangement, the IgL loci remain tightly packed in heterochromatin to
prevent IgL gene rearrangement, and both IgH alleles are accessible to Rag1/2 [52].
Productive VDJH gene rearrangement and μ-expression from one allele signals for
transient downregulation of Rag1/2 and the un-rearranged allele returns to a
heterochromatin state to prevent further rearrangement [53]. Allelic exclusion requires
signaling from membrane bound μ-chains, but it does not require the pre-BCR since
allelic exclusion is maintained in the absence of SL and upon expression of truncated IgH
chains [46, 54-57]. Although not required for allelic exclusion, pre-BCR signaling is
required for proliferation and differentiation to subsequent B cell stages, including the
initiation of IgL gene rearrangement [58].
Pre-BCR signaling relaxes the IgL loci to a euchromatin state, and Rag1/2 are
upregulated to initiate rearrangement of the IgL loci [59] [60]. Successful rearrangement
of IgL and subsequent BCR expression mediates tonic signaling that is required for B cell
survival [48]. If the BCR is self-benign, then Rag1/2 expression is turned off.

20
Unrearranged, or non-productively rearranged, loci are condensed into heterochromatin,
and the cell maintains expression of a single IgH and IgL chain yielding BCR with a
singular specificity. A strong BCR signal during B cell development indicates
autoreactivity and is believed to maintain Rag1/2 expression resulting in subsequent IgL
gene rearrangements to eliminate self-reactivity.
Characterization of B cell Development in the BM by Surface Protein Expression
Multiple labs were using flow cytometry to make exciting discoveries regarding B cell
development; however, each lab devised independent nomenclature that led to confusion
in the field. The experiments by Hardy et al. [61] used single letter designations to define
B cell stages, whereas others used terms like “pre-pro-B” and “pre-B”. Hardy’s B cell
nomenclature is the most widely used to define B cell development and was delineated
through characterization of FACsorted B cell precursors cultured in vitro (Figure 9 is a
summary of cell surface phenotypes during B cell development).
Expression levels of several cell surface proteins, termed “markers,” have been used
to discern the stages of B cell development. The biological function of these markers are
known in some cases, but others are currently unknown. B cells are derived from
hematopoetic stem cells (HSC) (Fig. 8) that give rise to all cell types in the blood [62].
The multipotent progenitor (MPP) gives rise to the common myeloid progenitors (CMP)
and early lymphoid progenitors (ELP) [63]. CMPs generate innate immune cells (eg.
neutrophils, monocytes/macrophages), and ELPs give rise to lymphocyte cells (B, T, and
NK) [64-68] . It is now believed that the major branch point for B and T cells occurs at
the stage where ELPs become common lymphoid progenitors (CLP) or early T cell
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progenitors (ETP) [69]. The CLP was originally believed to be the branch point between
B and T cells because both B and T lineage cells could be derived from this population
[70]. Indeed, CLPs have the capacity to give rise to both B and T cells, but they have a
propensity to generate B lineage cells [68]. It is likely that CLPs are not a major source
of T cells in vivo since they are not readily detected in the blood and therefore are not
frequently trafficking to the thymus for T cell differentiation [71]. In contrast, ETPs are
readily found in the blood and have been shown to home directly to the thymus and
therefore likely constitute the majority of T cell progenitors in vivo [71, 72].
CLPs express transcription factors and surface proteins that are essential to B cell
development. The cell surface phenotype of CLPs is Sca-1lo c-kitlo Flt3+ IL-7Rα+. C-kit
and Sca-1 are highly expressed on HSCs and ELPs but are downregulated as cells
differentiate [73, 74]. Flt3 is a receptor tyrosine kinase for Flt3-ligand and is required for
early development of B lineage cells [75]. IL-7Rα is a cytokine receptor that forms
heterodimers with the common γ-chain and binds the cytokine IL-7, which is a survival
and proliferation factor essential for murine B cell development [76].
The earliest defined stage for B cell development is the pre-pro-B stage (Fraction A)
marked by expression of an isoform of the phosphatase CD45 called B220 (Fig. 9) [77].
Expression of B220 is fairly unique to B-lineage cells, however some non-B cells also
express this isoform. Use of the AA4.1 monoclonal antibody allowed researchers to
discern B lineage precursors from other B220+ cells that do not give rise to the B lineage
[78]. AA4.1 recognizes a putative complement receptor classified as CD93; however, the
exact function of this molecule during B-lymphopoiesis remains unknown. In addition to
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B220 and AA4.1(CD93), pre-pro-B cells also express CD43, which has been implicated
in cellular adhesion [79]; however, its actual function during B cell development also
remains unknown.
Pre-pro-B (Fraction A) cells become Pro-B cells (Fraction B/C), which is the first
truly committed B-lineage stage (whereas CLP and pre-pro-B can still differentiate into
other lineages) [80-82]. Pro-B cells undergo proliferation in an IL-7 dependent manner
and begin to express the pan B cell marker CD19, which functions as a co-receptor for
pre-BCR and BCR signaling. CD19 is expressed on B cells through maturity and is often
used to identify B cell populations in the periphery. It is at this stage that DJH and V-DJH
rearrangements occur, and upon productive μ expression, the cells enter the early pre-B
cell stage (Fraction C’)[80].
Pre-B cells express the pre-B cell receptor, which is formed by μ-chain paired with SL
[44, 45]. Signaling through the pre-BCR expands pre-B cell clones expressing a μ-chain
that will likely pair with conventional IgL chain later in development [83]. Pre-BCR and
IL-7 signaling synergize to induce proliferation of “large pre-B cells”, which were
named due to their larger size as a result of their blasting phenotype [84]. Pre-BCR
signaling feeds back to downregulate SL expression and attenuate pre-BCR mediated
proliferation, marking progression to the late pre-B stage (Fraction D) [85].
Late pre-B cells (Fraction D) downregulate IL-7Rα expression, become CD43neg and
begin rearranging their IgL genes in order to form the conventional BCR [61]. Mice have
two IgL loci designated κ and λ. Rearrangement of IgL genes favors the κ locus as 9095% of B cells express Igκ light chains [86, 87]. Rearrangement and expression of IgL
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that pairs with μ-chain constitutes the conventional B cell receptor (BCR), which is
expressed on the cell surface and tested for self-reactivity.
If the BCR does not recognize self, then these cells are permitted to leave the bone
marrow as immature B cells (Fraction E). However, if the BCR is self reactive, then
there are opportunities to alter the BCR specificity though receptor editing [33]. If edited
B cells continue to have a high affinity for self-ligands, then they undergo apoptosis [88,
89]. In some instances, cells with low level autoreactivity exit the BM and are
maintained in an unresponsive state known as anergy [90].
In summary, B cell development in BM is a highly selective process in which only a
small fraction (10%) of B cell precursors survive all developmental stages and enter the
periphery as immature B cells [91].
Transition to Maturity: Continued B cell Development in the Periphery
Type 1 Transitional B cells (T1 B)
Immature B cells exiting the BM enter the periphery where they undergo a two step
transition to become mature follicular B cells (FO B) or marginal zone B cells (MZB)
(Fig 10). Type 1 transitional B cells (T1 B) are detected in the blood and migrate to the
spleen with the cell surface phenotype AA4.1+ IgMhi IgDneg CD21neg CD23neg [92](Fig.
10). They also are extremely sensitive to apoptosis induced by BCR crosslinking and are
excluded from the follicular regions of the spleen [93, 94]. T1 B cells do not respond to
the survival cytokine BAFF (B cell activating factor) due to decreased expression of
BAFF receptors TACI and BR3 [95, 96]. In the spleen, T1B cells differentiate into type
2 transitional B cells (T2 B).
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Type 2 Transitional B cells (T2 B)
Adoptive transfer of T1 B cells into irradiated hosts demonstrated that these cells give
rise to T2 B cells [97]. The maturation process coincides with surface expression of
CD21, CD23 and low level IgD, expression and migration to the B cell follicular area
(Fig. 10). T2 cells are mainly found in the spleen, although some T2-like cells have been
described in the BM [98], and unlike T1 B cells that die upon BCR crosslinking, the T2 B
cells undergo proliferation and upregulate BAFF receptor expression which mediates
survival signaling [94-96]. These T2 B cells will become either FO B cells or MZB cells
depending on the signals they receive while in the spleen.
A third subset of transitional cells designated T3 B shares characteristics with the T2
subset, except that T3 B cells have lower surface IgM expression [92]. The T3
population has a rapid turnover rate and is hypothesized to be either a transient
intermediate between the T2 and mature B cell stage or an anergic B cell population that
may have undergone BCR stimulation. Consistent with the anergy hypothesis, the BCRs
encoded by T3 B cells tend to be autoreactive [99]; however, adoptive transfer studies
will be required to determine whether cells in the T3 population are a developmental
intermediate.
In the next section I will first discuss the functional differences between mature
follicular and marginal zone B cells, followed by a description of cell intrinsic and
environmental cues that direct transitional B cells to a marginal zone or follicular B cell
fate.
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Functional and Developmental Differences Between Marginal Zone and
Follicular B cells
Immune Responses by Follicular and Marginal Zone B cells
Two major cell types arise from T2 B cells - follicular B cells (FO B cell) and
marginal zone B cells (MZ B cells). These cells have unique surface phenotypes (Fig.
10) and respond differently to infection. FO B cell responses require two signals. The
first signal is antigen mediated BCR crosslinking and the second signal is engagement of
CD40 (on the B cell surface) by CD40-ligand (expressed by cognate T helper (TH)
cells)[100-103]. The requirement for two signals during B cell activation reduces
inappropriate immune responses to self-antigens by requiring both the B cell and TH cell
to be activated simultaneously by a common stimulus. The CD40/CD40-ligand
interaction brings the B and TH cell in close contact allowing for paracrine cytokine
secretion that drives B cell proliferation and differentiation [104, 105].
TH and B cell interactions occur at the edge of the B cell follicle and T cell zone, and
upon activation, B cells migrate to germinal centers [106, 107]. The germinal center is
comprised of activated proliferating B cells attempting to increase their BCR affinity
through single point mutations in their Ig genes that alter the amino acid sequences in the
antigen binding domain [108]. Affinity maturation is a random process that can generate
clones of higher or lower affinity BCR depending on the mutations introduced. The
affinity maturation process requires specific enzymes to induce somatic mutations in Ig
genes and are described in a subsequent section (B cell Development in Rabbit).
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Follicular dendritic cells (FDC) are specialized antigen presenting cells found within
germinal centers that positively select high affinity B cell clones. FDCs display native
antigens bound to complement receptors on their surface, and B cells with high affinity
for those antigens will remain closely associated with the FDC [109] . Positive selection
is mediated through local BAFF secretion by FDCs that acts on nearby B cell clones. B
cells unable to express Ig (through introduction of stop codons) or those with lower
affinity BCR will not maintain close contact with the FDC and will undergo apoptosis
due to insufficient BAFF signaling [110]. Some of the germinal center B cells will
differentiate into antibody secreting plasma cells and others will become memory B cells
that re-circulate in the periphery and quickly respond to future infections by the same
pathogen. Isotype switch (from μ to γ, ε, or α) also occurs in the germinal center
allowing high affinity antibodies to mediate specialized effector functions (e.g. IgG1
binds to FcγRI on macrophages to promote phagocytosis/microbial killing) [111].
Unlike FO B cells that require two signals for B cell activation, MZ B cells do not
require T cell help to become activated [112]. TLR signaling is sufficient to activate MZ
B cells, which led to their classification as innate-like immune cells. MZ B cells reside in
the space between the white pulp and red pulp termed the marginal zone where they can
readily sample the circulating blood for microbial pathogens [113]. MZ B cells highly
express the complement receptor CD23 that binds complement coated microbes and MZ
B cells are hypothesized to shuttle complement bound antigens from the marginal zone to
the FDC surface in germinal centers [114]. This shuttling mechanism facilitates TH
dependent FO B responses to blood borne pathogens.
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MZ B cells also express high levels of CD1d, which is an MHCI-like molecule that
presents lipid antigens to natural killer T cells that can initiate or augment the immune
response through cytokine secretion [115]. The high surface expression of CD23 and
CD1d suggests that MZ B cells are in a semi-activated state and their localization in the
marginal zone allows for rapid immune responses to systemic infections [116]. Activated
MZ B cells also differentiate into short lived antibody secreting cells that reside in the red
pulp area of the spleen; however, these cells do not undergo Ig class switch nor do they
become memory cells [117].
Tonic Signaling in MZ and FO B cell Development
Conditional knockout studies have shown that ablation of BCR signaling results in
total loss of central and peripheral B-lineage cells [48]. This observation led to the
hypothesis that low levels of signaling, termed tonic signaling, are required for resting B
cell maintenance; however, strong BCR signaling in the absence of secondary signals
results in B cell apoptosis or anergy [90]. Therefore, the level of BCR signaling in
developing and resting B cells must reach an optimal level. FO and MZ B cell
development from T2 B cells is dependent on several factors, including the levels of tonic
BCR signaling.
There is a range of tonic signal strengths within developing B cells that, in part, dictate
T2 B lineage differentiation into FO or MZ B cells. The three relative levels of tonic
signaling are low, intermediate and high, all of which are lower than the levels of BCR
signaling in activated or autoreactive B cells. T2 B cells with low levels of tonic
signaling are predisposed to the MZ B cell pathway, whereas cells with relatively high
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levels of tonic signaling become FO B cell lineage [118, 119]. More recently, a second
population of FO B cells (FO B II) have been characterized and are believed to exhibit
low to intermediate tonic signaling and have a similar phenotype to MZ B cells (Fig.
10)[120]. FO II B cells reside in the B cell follicles but are hypothesized to replenish the
MZ B cell compartment in response to infection [121].
Notch Signaling During MZ B cell Development
Signaling through the Notch pathway is required for MZ B cell development [122]. In
vivo studies have shown that deletion of Notch-2 (expressed on MZ B cell precursors) or
the Notch-2 ligand delta-like 1(DL-1) results in complete loss of MZ B cells with no
effect on FO B cell development [122, 123] . Consistent with this observation, the
deletion of genes that suppress Notch signaling increase the size of the MZ B cell
compartment; moreover, mutating the glycosyl tranferases that augment the strength of
Notch-2/DL-1 interaction decreases the MZB cell population [124]. DL-1 is expressed in
venules within the splenic red pulp adjacent to the MZ, suggesting this area could be a
site for MZ B cell differentiation and maintenance [124].
NFκB Signaling During FO and MZ B cell Development
Mice deficient in NFκB1 lack MZ B cells suggesting that NFκB signaling is critical
for MZ B cell development [125]. Two pathways for NFκB signaling have been
identified and termed the canonical and non-canonical NFκB pathways. These pathways
differ in the proteolytic cleavage of the NFκB precursor, p100 [126]. The non-canonical
pathway cleaves p100 into p52, which is required for BAFF-mediated survival signaling
in immature and transitional B cells [127]. BAFF also has the capacity to signal via the
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canonical pathway (p100 processed to p50), which is important for survival of FO B cells
and differentiation of MZ B cells [128, 129].
Mice heterozygous for both Notch-2 and p50 lack the MZ B cell compartment with no
apparent loss of FO B cells, suggesting that a single copy of p50 is sufficient for B cell
survival but not MZ B cell differentiation [130]. Constitutive activation of the canonical
NFκB signaling pathway restores the MZ B compartment in BAFF deficient mice leading
to the current hypothesis that p50 and Notch-2 synergize to promote MZ B cell
development [131]. Current studies are aimed at identifying overlapping gene targets of
NFκB p50 and Notch-2 that drive MZ B cell development [121].
B-1 B cells: An Independent B cell Lineage
Mice contain two major lineages of B cells, B-1 and B-2 [132]. The MZ and FO B
cells arise from a common BM derived progenitor and are designated B-2 lineage. In
contrast, B-1 lineage cells are largely derived from fetal progenitors and are maintained
as a self-renewing population after birth [133]. B-1 cells are polyreactive, which means
they engage in low-level interactions with a variety of self and non-self moieties, and the
antibodies generated by B-1 B cells are a first line of defense against systemic bacterial
infection [134, 135]. B cell development in the fetus has several differences from postnatal B cell development in the BM. Fetal B cell development occurs in the liver with a
bias toward utilization of the DH -proximal VH genes (7138, Q52, VH12) [136]. These
rearrangements also have limited DH gene usage and junctional diversity due to the lack
of terminal deoxynucleotidyl transferase (TdT) expression [137-139]. Several of the VH
genes commonly utilized in fetal development do not pair with SL (VH81x, VH11, VH12)
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and therefore do not emit strong pre-BCR signals. Weak pre-BCR signaling in the fetal
liver is advantageous since strong pre-BCR signaling results in developmental arrest
[140]. This is in contrast to B cell development in the BM where strong pre-BCR signals
drive pre-B cell proliferation.
The limited VH gene usage and lack of junctional diversity led to the “evolutionary
memory” hypothesis that fetal derived VH/VL combinations have natural specificities for
ubiquitous pathogens encountered after birth [113]. Experiments using VH12-μ chains
provide some evidence for evolutionary memory. VH12-μ chains typically do not pair
with SL nor do they pair well with most conventional IgL chains; however, when VH12-μ
pairs with Vκ4/5H during B-1 B cell development, the BCR is specific for
phosphorylcholine (PC) [139]. These antibodies bind PC in bacterial cell walls and
provide significant protection from pneumococcal infection . The protective effects of
VH12/Vκ4/5H are lost upon enforced expression of TdT during fetal B cell development,
suggesting that TdT is not expressed during fetal development because it eliminates the
germline encoded specificity of select VH/VL pairs [141].
Most B-1 B cells reside in the pleural and peritoneal cavities with only few B-1 cells
found in the blood and spleen [133]. It was hypothesized that B-1 cells were of a
different lineage than B-2 cells and early studies identified B-1 precursors in fetal liver.
Reconstituting lethally irradiated adult mice with fetal liver cells restored both B-1 and
B-2 cells, whereas reconstitution with adult BM cells readily restored the B-2 population
but yielded very few B-1 cells [142]. These experiments indicate that the B-1 B cell
progenitors are not abundant in adult BM and that most B-1 B cells are likely derived
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during fetal development. A second hypothesis was that the peritoneal cavity housed the
B-1 progenitor cells; however, Igneg peritoneal cells were unable to give rise to the B-1
lineage [143, 144]. Surprisingly, transfer of the Ig+ peritoneal cells to irradiated hosts
was sufficient to restore and sustain the B-1 B cell population, supporting the hypothesis
that B-1 B cell progenitors are likely fetal derived and maintained by a self-renewing
population [144].
Recent studies have identified B-1 B cell progenitors in both the yolk sac of 9 day old
fetuses and in the adult spleen [145, 146]. The splenic B-1 progenitors are quiescent in
adults but undergo expansion in vivo in response to LPS. The current hypothesis is that
B-1 B cells in adult mice are largely maintained by self-renewal in the peritoneum, but
that B cell depletion in response to infection expands the splenic B-1 B cell progenitors to
replenish the B-1 B cell compartment [146]. More studies using infection models will be
required to determine the biological significance of these splenic B-1 B cell progenitor
cells.
B-1 B cells are divided into two groups, B-1a (CD5+) and B-1b (CD5neg) [132]. The
exact significance of CD5 expression in the B-1 compartment is not completely
understood. CD5 is hypothesized to dampen BCR and TCR signaling, but CD5-/- mice
have no apparent defect in B and T cell populations [147]. In some cases, CD5 can be
upregulated upon encounter with antigen, and the polyreactivity of B-1 B cells may
provide continuous BCR stimulation resulting in increased CD5 expression [148].

35
B cell Development in Rabbit: A Comparison with Mouse
B cell Development in the BM
Rabbit B cell development in the BM is fairly similar to murine B cell development,
but there are also some striking differences. Like mouse, rabbit B cells develop from
stem cells in the BM and transition through the pro-B, pre-B and immature B cell stages
[149]. B cell development in both rabbit and mouse declines with age; however, in
rabbits, B lymphopoiesis declines soon after birth and within 2-4 months pro-B and pre-B
cells cannot be detected in the BM (Fig. 11)[150, 151]. In mouse, B cell development
never completely turns off, and the decline in B lymphopoiesis is more gradual and
begins later in life. The abrupt cessation of B lymphopoiesis in rabbit is not due to stem
cell defects, as adult B cell progenitors develop into B lineage cells in vitro or upon
adoptive transfer to young irradiated rabbits [149]. The current hypothesis is that the
stroma of adult rabbits is non-permissive to B cell development, and our lab has some
data indicating that inhibition of B lymphopoiesis by adult stroma is through a secreted
factor (Bilwani and Knight, unpublished).
Rabbits, like humans and mice, have many (~100) VH genes available for IgH gene
rearrangement, yet rabbit B cell development is biased toward utilization of the 3’ most
VH gene, VH1 (Fig. 12)[16]. The VH1 gene is utilized in >80% of rearrangements, with
the remaining 20% utilizing genes located ~100 kb upstream (VHx, VHy, VHz). Restricted
VH gene usage yields an initially limited B cell repertoire that exits the BM and migrates
to the gut associated lymphoid tissue (GALT) for the second stage of B cell development
where the VDJH genes undergo somatic diversification.
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B cell Proliferation and Ig-gene Diversification in GALT
B cells migrate from the BM and enter GALT, which in rabbits consists of the
appendix, Peyer’s patches, and a Peyer’s patch-like structure called the sacculus rotondus
located at the ileal-cecal junction. The rabbit appendix is remarkably large, comparable
in size to the human appendix, and is the most prominent GALT structure in rabbits.
Immature B cells from the BM are hypothesized to seed GALT for only the first 8 weeks
of life [152]. This initial B cell population is then expanded and undergoes somatic
hyper-mutation (SHM) and gene conversion (Fig. 13)[153].
SHM is a process by which point mutations are introduced into the DNA and alter the
coding sequence. These mutations can be silent (no change in coding sequence),
missense (change in coding sequence) or non-sense (encodes stop codon). Gene
conversion provides diversity through introducing stretches of nucleotides from upstream
VH genes into the rearranged VDJ exon through homologous recombination. Gene
conversion is a major mechanism utilized by rabbit and other species but has not been
observed in mouse and human B cells [154-157].
SHM in mouse occurs in the germinal centers where B cells mutate their Ig genes, and
the highest affinity clones are selected. B cells with Ig mutations that reduce BCR
affinity or introduce stop codons undergo apoptosis. In addition to SHM, germinal center
B cells undergo class switch recombination to other Ig constant regions [158]. In the
peripheral lymph nodes and spleen, most of the germinal center B cells class switch from
IgM to the IgG isotypes that facilitate uptake of microbes and their products by
phagocytic cells. B cells in mucosal tissue class switch to IgA, which is the predominant
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Ig secreted in the mucosa [159]. SHM and gene conversion in rabbit GALT is believed
to occur within the proliferating B cells at the base of the follicle and these processes
require intestinal bacteria (described below). Unlike mouse germinal center B cells that
simultaneously undergo SHM and class switch recombination, most of the rabbit B cells
in GALT diversify their Ig genes but maintain the IgM isotype.
SHM and gene conversion require the enzyme activation-induced cytosine deaminase
(AID) that was originally described as an RNA editing enzyme but also works on DNA
during SHM, gene conversion and class switch recombination [160, 161]. AID is
actively recruited to transcribed Ig genes and deaminates cytidine to uracil on both
coding and non-coding strands [162]. The G-U mismatches generated by AID are
recognized by the base excision repair pathway or the mismatch repair pathway that
remove the uracil residue and allow for error-prone DNA polymerases to introduce point
mutations and alter the coding region. During gene conversion, AID generates double
stranded DNA breaks allowing for stretches of upstream VH regions to recombine with
the rearranged VDJH exon, and a similar event occurs at the switch regions of the Ig
constant regions during class switch recombination [163]. AID is coordinately expressed
with the onset of VDJH gene diversification at the base of the B cell follicles in GALT
(Lanning, unpublished), and based on studies in mouse, AID is almost certainly required
for the diversification of the rabbit B cell repertoire.
GALT: A Potential Reservoir for Self-renewing B cells
It is intriguing to consider how rabbits maintain their peripheral B cell populations
throughout life in the absence of newly made B cells in the BM. One hypothesis is that B
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cells in the GALT are continuously stimulated through superantigen molecules that
stimulate heterogeneous B cell populations by binding and crosslinking the BCR outside
of the conventional antigen binding domain. Superantigens that stimulate rabbit BCR are
predicted to bind the structural framework regions (FR) and mediate polyclonal
stimulation [164, 165].
The Mage lab suggested CD5 as a potential superantigen for rabbit B cell stimulation
based on the ability of CD5 to bind appendix B cells and the interaction of CD5 with
select VH domains. All peripheral B cells in rabbit express CD5, and in mouse, CD5
marks the self-renewing B1a B cell compartment [166]. The Knight lab proposed that
superantigen-like molecules are derived from commensal bacteria and bind to VH or VL
and polyclonally stimulate B cells in GALT (Fig. 14) [164]. Constructs containing the
Ig-VH and VL domains that form an Fv molecule were able to bind subsets of spore
forming commensal bacteria, and polyclonal serum IgM can bind directly to Bacillus
spores. Additionally, spores from a non-pathogenic strain of B. anthracis were sufficient
to induce B cell proliferation in GALT, in a manner that depended partly on the presence
of the spore surface [167]. The direct binding of polyclonal IgM to spores combined with
decreased B cell follicle formation in the presence of spores with altered surfaces
supports the notion that bacterial derived superantigens promote B cell
proliferation/survival in rabbits; however, the exact superantigen-like molecule(s) and
their binding sites on VH or VL remain to be determined.
Until recently, peripheral B cells in rabbits were generally indistinguishable from each
other and questions arose as to whether all peripheral B cells have the capacity of self-
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renewal or if a select subset of B cells continuously repopulates the periphery. The
proliferating B cell population in GALT is an attractive candidate as a reservoir of selfrenewing B cells, and recently, Yeramilli and Knight identified a transitional type 1 B
cell in the rabbit appendix [168] . These cells have the same surface phenotype as human
T1-B cells, and similar to human they die upon BCR crosslinking. Unlike mouse and
human, the T1-B cells in rabbit have diversified VDJH genes and are therefore designated
T1d B cells (“d” for diversified VDJH genes). Current studies are determining if the T1d
B cell population is capable of self-renewal.
GALT/Gut Microbes are Required for B cell Expansion and Ig Diversification
B cells in GALT diversify their Ig genes and undergo robust proliferation in organized
B cell follicles. These processes were found to require both GALT and the intestinal
microbiota. Surgical removal of GALT in newborn rabbits (GALTless) results in a near
absence of Ig gene diversification and decreased populations of peripheral B cells [169].
Similarly, VDJ gene diversification and B cell expansion do not occur when the appendix
is made sterile through surgical ligation at birth. Small B cell clusters are present in germ
free appendices, indicating that ligation does not affect the initial seeding of GALT;
however, the architecture of the B cell follicles was strikingly different compared to
normal appendices (Fig. 15) [167, 170]. Reversing the appendix ligation to allow
colonization by the intestinal bacteria or injection of select members of the intestinal
microbiota into the ligated appendix restores B cell proliferation and diversification.
The GALTless and ligated appendix studies demonstrate unequivocally that both
GALT and the intestinal microbiota are required for expansion and diversification of the
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pre-immune B cell repertoire in rabbits. The two step process that generates the rabbit
primary B cell repertoire (Step 1, BM; Step 2, GALT) is shared amongst several other
species, referred to as GALT species, including chicken, sheep, cow and pig. However,
the mechanisms by which GALT and commensal microbes drive B cell repertoire
diversification and whether GALT is required for maintaining peripheral B cell
populations are still under investigation.
Early Stages of B cell Development in BM: Pro-B Cell Stage
Transcription Factors E2a and Ebf: B-lineage Specification
Stem cells restricted to the lymphoid lineage still have the capacity to differentiate into
multiple cell types (B, T, NK), and it is the combination of transcription factors expressed
within these progenitors that dictates cell fate. Some transcription factors direct cells
toward particular lineages. For example, enforced expression of early B cell factor (Ebf)
during the hematopioetic stem cell stage results in development toward the B lineage
[171]. Expression of transcription factors that increase the propensity of one lineage over
another are said to mediate lineage specification but not necessarily commitment.
Commitment implies a “point of no return” where the cell loses its capacity to
differentiate into other cell types [172].
The E2a gene encodes two transcription factor splice variants (E12 and E47) that are
expressed in lymphoid restricted progenitor cells [173]. These variants bind to DNA as
homodimers, and deletion of E2a results in a developmental block at the pre-pro-B cell
stage [174]. E2a-/- pre-pro-B cells have decreased Rag1/2 expression and do not
rearrange their Ig genes [175, 176]. Other B-lineage genes are also downregulated in the
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absence of E2a, including Igα, λ5, and CD19; however, there is no change in the
expression of IL-7Rα, Igβ, or μ germline transcripts [175, 177]. Most importantly, E2a
works in conjunction with IL-7R signaling (via STAT5) to induce Ebf expression (Fig.
16a) [178, 179].
Ebf expression is initiated at the pre-pro-B cell stage and is maintained until B cell
differentiation into plasma cells [176]. Ebf regulates many overlapping genes with E2a
(Fig. 16A), and deletion of Ebf results in a similar phenotype to E2a-/- mice with a block
between the CLP and pre-pro-B cell stage [180]. The similar phenotypes of E2a-/- and
Ebf-/- mice suggest that these transcription factors regulate many of the same genes in a
cooperative fashion. E2a+/- Ebf+/- mice also exhibit a block at the pre-pro-B cell stage
with similar decreases in B-lineage gene expression, which strengthens the notion that
high levels of both E2a and Ebf are required for expression of B-lineage genes during
early B cell development [181]. Further, ectopic co-expression of Ebf and E2a in non-B
cell lines was sufficient to induce Rag gene expression and DJ gene rearrangement,
suggesting that a major function of these two transcription factors is to initiate Ig gene
rearrangement [182].
Transcription Factor Pax5: B-lineage Commitment
Pax5 is a transcription factor required for B-lineage commitment and maintenance.
Pax5 is expressed from the pro-B cell stage through maturity, and like Ebf, Pax5 is
downregulated upon plasma cell differentiation [183]. B cell development in Pax5-/- mice
is completely blocked at the early pro-B cell stage, indicating that Pax5 is required during
B cell development [81]. Pax5-/- pro-B cells can be cultured in vitro, and addition of
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cytokines and/or receptor ligands that promote other lineages allowed Pax5 pro-B cells
to differentiate into multiple cell types (e.g. M-CSF macrophage; DL-1 T cell; GMCSFdendritic cell) [82]. Further, reconstitution of irradiated mice with Pax5-/- pro-B
cells gave rise to all other hematopoietic cell types except for B-lineage cells [82, 184,
185]. These experiments demonstrate that Pax5 is required for both B cell development
and B lineage commitment.
Conditional knockout of Pax5 in committed pro-B cells resulted in decreased
expression of B-lineage markers and these cells regained their plasticity to become other
cell types [186]. Similarly, deletion of Pax5 in mature B cells results in decreased
responses to antigen, loss of B cell specific markers and increased expression of genes
associated with other lineages [187]. These data demonstrate that Pax5 is also required
for life long commitment to the B-lineage.
Ebf induces Pax5 expression during the pre-pro-B cell stage, then Pax5 regulates itself
through an auto-feedback loop in conjunction with Ebf (Fig. 16B) [188] [189, 190].
Enforced Pax5 expression in the absence of Ebf is not sufficient to rescue the B-lineage,
indicating that Ebf has independent functions during B cell development other than
maintaining the expression of Pax5 [172]. It is estimated that Pax5 represses more than
100 genes, many of which are normally expressed in progenitor cells, other hematopoetic
lineages, or during B cell differentiation into plasma cells (Fig. 16B)[191]. Pax5 is also a
positive regulator of several B cell specific genes and promotes V-DJH rearrangement by
making upstream VH genes (J558 family) accessible to Rag1/2 [43]. The combined
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characteristics of large scale gene regulation and requirement for B-lineage commitment
led to the classification of Pax5 as a master regulator of B cell development.
IL-7 Signaling
Pro-B cell survival, growth and differentiation require the cytokine interleukin-7 (IL7). IL-7 was discovered by screening cDNA libraries from BM stroma for mitogneic
growth factors [192]. B-lineage cells were found to undergo robust proliferation when
cultured with IL-7, and subsequent antibody mediated blocking experiments, in which
IL-7 was prevented from interacting with IL-7 receptor (IL-7R), demonstrated the
requirement for IL-7 signaling during B cell development [193, 194]. Deletion of IL-7
and IL-7R genes in mouse provided genetic evidence that IL-7 was required for early B
cell development in vivo [76, 195, 196]. Consistent with observations in mouse, studies
in our laboratory also demonstrate the requirement for IL-7 at the early stages of B cell
development in rabbit [149]. In contrast, human B cell development does not require IL7 as evidenced by normal B cell populations in human patients bearing mutations that
affect IL-7Rα or γc expression and function [197]. Additionally, in vitro culture studies
confirmed that IL-7 is not required for human B cell development [198], marking an
evolutionary difference in the requirements for B cell development among species.
Although IL-7 is not required for human B cell development, it is almost certain that
without the discovery of IL-7, many of the in vitro experiments using mouse models to
elucidate B cell development pathways would not have been possible.
IL-7R is a heterodimer of IL-7Rα, which provides specificity for IL-7, and the
common-γ chain (γc) that is shared with several other interleukin receptor α-chains (e.g.
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IL-2, IL-4, IL-6). IL-7 binding to the IL-7R mediates cross phosphorylation of JAK
family kinases (Jak1 and Jak3) which in turn phosphorylate IL-7Rα [199, 200].
Phosphorylated IL-7Rα provides docking sites for signal transducer and activator of
transcription (STAT) proteins, with STAT5 being most important for normal B cell
development (Fig. 17) [201]. STAT5 coordinately upregulates the expression of antiapoptotic factors (Bcl-2, Bcl-xl, Mcl-1) and downregulates expression of pro-apoptotic
factors (Bim, Bax, Bad) resulting in increased B cell survival [202-204]. Proliferation
induced by IL-7 signaling is orchestrated by multiple pathways that require
phosphorylation of JAK1/JAK3 and phosphorylation of the IL-7Rα chain. IL-7R
signaling promotes proliferation by activation of PI3K, which blocks the nuclear
translocation of cell cycle inhibitors [205, 206] [207]. IL-7R signaling also induces the
transcription factors N-myc and C-myc which are positive regulators of cell cycle [208].
STAT5 and E2a upregulate Ebf which in turn promotes expression of Pax5 resulting
in B-lineage commitment [178, 179]. Constitutively active STAT5 is sufficient to rescue
B cell development in IL-7R-/- mice, whereas enforced expression of Ebf only restored Blineage differentiation but did not rescue proliferation [209-211]. This suggests that the
function of STAT5 with regard to proliferation is independent of B lineage commitment
mediated by Ebf. Expression of IL-7R receptor is controlled by several transcription
factors: Miz-1 [212], c-myb [213, 214], FOXO-1 [215] and PU.1 [216], all of which are
required for normal B-cell development in response to IL-7. However, the earliest stage
at which IL-7 is first required for B cell development is controversial. One report
suggests that IL-7R signaling is required for the CLP to pre-pro-B cell transition [217]
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and others suggest it is required at the pre-pro-B to pro-B cell transition [178, 218]. In
either case, the CLPs and pre-pro-B cells stages still have some plasticity and can revert
back to other cell lineages (T cells, NK cells), indicating that IL-7 signaling alone does
not commit cells to the B lineage.
VDJ Gene Rearrangement
Typically, the DJH genes on both IgH alleles are rearranged prior to the pro-B cell
stage [40]. DJH rearrangement does not signify B lineage commitment since many T
cells also possess rearranged Ig DJH genes [42]. VH to DJH rearrangement coincides with
B lineage commitment during the pro-B to pre-B cell transition [43]. VH-DJH
rearrangement during B cell development in mouse BM is biased toward utilization of
upstream VH gene families (e.g. J558). Increased J558 gene usage is partially due to IL7/STAT5 signaling and Pax5 expression, which increase chromatin accessibility of distal
VH genes by inducing histone acetylation [52, 219]. Parallel studies investigating
germline transcription at the Igκ loci found that STAT5 suppresses κ germline
transcription that precedes Ig gene rearrangement [220, 221]. The decrease in Vκ
germline transcripts, in conjunction with the increase in VH germline transcripts, may
explain the ordered rearrangement of IgH genes followed by IgL genes during B cell
development. Upon productive rearrangement and pre-BCR signaling, the accessibility
of distal VH genes decreases, coinciding with reduced IL-7 responsiveness, suggesting
that loss of IL-7 signaling may be required for allelic exclusion [222]. However,
enforced IL-7 signaling through constitutively active STAT5 is not sufficient to break
allelic exclusion, suggesting that downregulation of IL-7 signaling may contribute to, but
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is not required for, allelic exclusion [223]. This may not be surprising since VH gene
accessibility is only one of many factors (e.g. Rag1/2 expression, DNA repair enzymes,
ect.) that are required for VDJ gene rearrangements.
Early Stages of B cell Development in BM: Pre-B Cell Stage
Ig Structure
In-frame VH-DJ rearrangement and µ expression marks the pre-B cell stage in which
IgH chains are tested for structural fitness through pairing with a light chain-like
molecule called surrogate light chain (SL) [224]. The function of a protein is dependent
on its structure. In some cases, protein function can be lost by a single amino acid
mutation. It is therefore important to have quality control mechanisms in place to ensure
that newly made proteins are functional. This is especially important when considering
Ig proteins since Ig diversity is derived through deliberate amino acid mutations that
could impair Ig folding/function. Each Ig domain consists of approximately 100 amino
acids forming a Greek-key β-barrel. The Ig constant domains consist of 7 strands
(a,b,c,d,e,f,g) (Fig. 18A), and the variable Ig domains have 9 strands (a,b,c,c’,c’’,d, e, f,
g)(Fig. 18B). These strands form two anti-parallel β-sheets in a sandwich-like structure
with an intramolecular disulfide (ds) bond spanning 60-70 amino acids that stabilizes the
Ig fold [3]. Ig domains are highly resistant to proteolysis and have been found in
eukaryotic species originating 750 million years ago, which is 250 million years prior to
the evolution of antibody based immunity. Ig folds have also been found in prokaryotic
proteins suggesting this structure is useful to a variety of organisms [225, 226]
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Ig Domain Folding: Autonomous and Obligate Homodimer Pathways
The main proteins used to study Ig folding are conventional IgL and Ig γ-chains)[227,
228], and observations made using these models are believed to be true for folding of μchains in the context of the BCR and pre-BCR [229]. All Ig transcripts possess a leader
region with an endoplasmic reticulum (ER) signal sequence that targets IgH for cotranslational translocation into the ER lumen, and some of the Ig domains begin to fold
spontaneously upon translocation [230]. Protein denaturing and refolding studies suggest
that the first regions to fold are the small helices located between strands a,b and e,f (Fig.
19) [231]. These helices guide the initial clustering of hydrophobic residues in the
central b,c,e, and f strands forming the hydrophobic core followed by stabilization by the
intramolecular ds bond [232, 233]. The rate limiting step for Ig domain folding is proline
isomerization in the linker between strands B and C from trans to cis (Fig. 19) [234].
Domains that only require trans-cis proline isomerization for complete folding are
considered to fold “autonomously.” Examples of autonomously folding domains are CL
and CH2 [235]. Other domains, such as γ-CH3, require homodimerization in order to
achieve their native structure. The proline isomerization and formation of the
hydrophobic core of γ-CH3 begins spontaneously, but achieving the lowest energy native
state requires contact with an adjacent γ-CH3 domain [236].
Template Assisted Ig Domain Folding
The CH1 domain is extremely disordered in the absence of IgL and therefore requires
the chaperone BiP (Ig Heavy chain binding protein) to prevent unfolded protein
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aggregates [237]. BiP is an ER resident chaperone of the HSP-70 family that was first
described in studies of pre-B cell lines [238, 239]. BiP has an affinity for hydrophobic
patches on misfolded proteins, including Ig [240]. BiP binds the Ig-CH1 domain and
retains unfolded Ig intermediates in the ER, and deletion of CH1 allows these partially
folded intermediates to exit the ER [241]. During Ig folding, conventional IgL (or SL)
replaces BiP and completes folding of the CH1 domain [242-244]. The guided folding of
CH1 by conventional or surrogate light chain requires intermolecular disulfide (ds)
bonding between CH1 and IgL (or SL) [245]. This process of coupling IgH/IgL
heterodimer formation with CH1 folding is called template assisted folding and is a
quality control mechanism that prevents IgH exit from the ER in the absence of IgL.
BCR and Pre-BCR Assembly in the ER
A model for the sequential steps of BCR (or Pre-BCR) folding described in this
paragraph is depicted in Figure 20. BCR and Pre-BCR assembly begins with the
autonomous folding of VH and CH2 domains with BiP binding to the disordered CH1
domain. The folding of CH2 occurs through obligate homodimerization of μ-chains, and
all domains, with the exception of BiP bound to CH1, are in their native conformations.
The template assisted folding of CH1 is the major rate limiting step in BCR (or pre-BCR)
formation and requires an intermolecular ds bond between IgH and IgL (or SL) followed
by BiP dissociation and complete folding of CH1. The completely folded BCR (preBCR) no longer binds BiP, proceeds to the trans-golgi network for glycosylation and
translocates to the cell surface for signaling.
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Surrogate Light Chain Structure and Function
SL is a two protein complex consisting of a VL-like domain called Vpre-B and a CLlike domain called λ5 [44, 45]. The two proteins are germline encoded and do not
undergo gene rearrangements as observed with IgH and IgL genes. These proteins are
expressed early in B cell development during the pro-B cell stage in anticipation of μchain expression [246]. λ5 was discovered through a cDNA screen for genes specifically
expressed in pre-B cells that identified a gene with strong homology to the IgL-λ1
constant region [45]. λ5 was puzzling because it only encoded for the C-terminal end of
a λ-light chain and lacked a VL domain. This λ-like chain had a conserved Ig fold with a
cysteine available for intermolecular ds bonding with μ, a JL -like sequence, and an Nterminal non-Ig sequence. In the following year, the “missing” VL domain was identified
in same locus as λ5 and was called Vpre-B [44]. Vpre-B and λ5 are encoded by separate
genes and form a non-covalent heterodimer that pairs with IgH forming the pre-BCR that
transits to the cell surface [247].
The structures of the SL and pre-BCR were accurately modeled based on amino acid
sequence data and mutagenesis studies [63, 248], which were later confirmed by X-ray
crystal structure analysis of the pre-BCR Fab-like domain [249]. These structures
indicate a unique protein/protein interaction between Vpre-B and λ5 in which the Vpre-B
domain lacks the 9th strand of conventional VL domains and is completed by a β-strand
encoded at the N-terminus of λ5 (Fig. 21). λ5 forms an intermolecular ds bond with CH1
in a manner similar to conventional IgL. The formation of the λ5-CH1 intermolecular ds
bond also requires Vpre-B indicating that both Vpre-B and λ5 are required for pre-BCR
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assembly. Vpre-B and λ5 have canonical Ig domains and unique non-Ig regions at their
carboxyl and amino termini, respectively. These domains are largely disordered and have
not been successfully crystallized [249]. The Vpre-B domain can interact with μ-chains in
the absence of λ5 [250]; however, λ5 is unable to bind μ on its own and requires the
presence of Vpre-B [244]. The inability of λ5 alone to associate with μ is hypothesized
to be due to the λ5-N-terminal non-Ig unique region (UR) since deletion of this region
allows for autonomous λ5 folding in the absence of Vpre-B [244]. The λ5-UR in
particular has been implicated in pre-BCR signaling (discussed later in this section).
SL-/- mice have a severe but incomplete block at the pro-B to pre-B cell transition [46,
47, 56]. With time, these mice acquire peripheral B cell populations that are believed to
arise from alternative pathways of B cell development that do not require the SL. One
mechanism is through rearrangement of the conventional IgL genes prior to or
concurrently with µ-chain expression [251]. This would allow for conventional BCR
signaling and bypass the need for pre-BCR signaling [252]. Alternatively, select CDR3
regions encoded by DH could allow for SL independent folding and surface-μ expression,
allowing for further B cell development [139, 253]. Interestingly, human patients with
mutations in SL remain B cell deficient for life suggesting that mechanisms allowing for
limited B cell development in SL-/- mice are not present in humans [254].
Polyclonal Stimulation through the Pre-BCR
Each μ-chain has a different specificity due to random VDJ gene rearrangement, yet
pre-B cell expansion occurs in response to pre-BCR crosslinking. Either all of these μchains are autoreactive and interact strongly with the bone marrow environment or there
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is a polyclonal stimulus that can activate a variety of pre-BCR complexes in an antigen
independent manner. Positive selection of autoreactive pre-B cell clones during B cell
development opposes the central hypothesis that the adaptive immune repertoire should
be self-tolerant and only specific for foreign antigens. Therefore, a polyclonal stimulus
that is independent of μ-chain specificity is a reasonable mechanism to expand a diverse
pre-B cell population and several studies implicate the SL-URs in mediating polyclonal
pre-BCR crosslinking [255-258].
In vitro studies of pre-B cell development showed that single pre-B cells can
proliferate in the absence of stromal cell contact suggesting that homotypic interactions
between adjacent pre-BCR or pre-BCR interaction with other surface molecules is
sufficient for pre-BCR crosslinking [30]. This in vitro observation does not eliminate the
possibility that stromal ligands enhance pre-BCR signaling and are required for pre-B cell
development in vivo. The first pre-BCR ligand was identified by staining BM stromal
cell lines with soluble pre-BCR, and the ligand was later identified as a sulfated form of
heparin [255, 258]. Similar studies using human pre-BCR identified Galectin-1 (Gal-1)
as a stromal derived pre-BCR ligand. Galectin-1 is highly expressed in the bone marrow
and induces pre-BCR clustering at the site of pre-B cell/stromal cell contact [256]. The
recognition of both heparin sulfate and Gal-1 required the λ5-UR but were independent
of the Vpre-B-UR, suggesting that polyclonal pre-BCR stimulation is mediated largely
through the λ5-UR.
The importance of the λ5-UR in pre-BCR signaling was demonstrated using pre-B cell
lines in which the λ5-UR was either deleted or voided of conserved arginine residues
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through mutation to threonine [257]. These mutations prevented pre-BCR aggregation on
the cell surface and reduced signaling through the pre-BCR, suggesting that not only is
the λ5-UR important for pre-BCR signaling but so is the distribution of positively
charged arginine residues. Furthermore, pre-B cell proliferation in mice expressing λ5
transgenes lacking UR was decreased by 50% with no apparent effects on pre-B cell
differentiation to the mature B cell stage [258]. The λ5-UR-/- mice do not exhibit a
complete block in pre-B cell proliferation suggesting that mechanisms independent of the
λ5-UR induce some pre-BCR signaling. These data suggest that the λ5-UR is critical for
normal pre-BCR mediated proliferation but not for B cell differentiation.
In summary, pre-BCR crosslinking can occur through interaction with ligands in the
stromal environment or by autonomous signaling through homotypic interactions with
adjacent pre-BCR (Fig. 22). Most of the pre-BCR crosslinking is likely through the λ5UR; however, other factors, including glycosylation of the μ-chain, may be critical to preBCR assembly and/or pre-BCR signaling. Therefore, the structural integrity of newly
synthesized μ-chains is measured based on the ability of μ to fold properly, pair with SL
and orient λ5 in proximity to stromal ligands or adjacent pre-BCR to facilitate signaling
and pre-B cell expansion.
Hypothesis for μ-chain Versus δ-chain Usage During Early B cell Development
As B-lineage cells reach maturity, they begin to express IgD (δ) on their surface. The
simultaneous expression of μ and δ isotypes is mediated by alternative splicing of the IgH
transcript [259]. Mature follicular B cells actually express more δ than μ, yet during B
cell development in the bone marrow, μ is exclusively expressed. Recent studies have
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found that δ-chains lack the capacity to pair with SL and that a single asparagine residue
(Asn 46) encoded by Cμ1, and absent in Cδ1, is required for SL pairing [260].
Glycosylation of Cμ1-Asn 46 is required for pre-BCR assembly and autonomous preBCR signaling; however, deletion of λ5-UR relieves the requirement for Cμ1-Asn 46
during pre-BCR formation, suggesting that interactions between the positively charged
λ5-UR and negatively charged glycans linked to Asn 46 may be important for efficient
pre-BCR assembly [260]. The fact that Cδ1 lacks Asn46 and does not form pre-BCR
may explain the delay in δ expression until after completion of B cell development in the
bone marrow.
Selection Against Autoreactive CDR3 by SL
Structural studies of the pre-BCR suggest that the Vpre-B and λ5 URs occlude the
antigen recognition domain of VH and was confirmed using an antigen specific IgH that
completely lost the capacity to recognize antigen when paired with SL [249]. The
inability of μ chains to recognize antigens in the context of the pre-BCR suggested that
the purpose of pre-BCR signaling was to test the structural fitness of μ and that screening
for self-reactivity occurs later in development. Recent data, however, implicates SL in
probing CDR3 for self-reactive properties. In SL-/- mice, there is substantially increased
prevalence of anti-nuclear antibodies (ANA) with nucleic acid specificity [261]. The
ANA level in the serum increases with age and is attributed to increased frequency of
basic amino acids (lysine and arginine) in the CDR3 that is characteristic of antibodies
that recognize nucleic acids. The positively charged side chains of Lys and Arg interact
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strongly with the negatively charged phosphodiester backbone of nucleic acids and this
interaction becomes stronger as the CDR3 becomes more basic [262].
Nearly 50% of pre-B cells from SL-/- mice have a CDR3 with basic amino acids,
whereas the frequency of basic amino acids in CDR3 of wt pre-B cells is only 25% [261].
It is hypothesized that this initial propensity for basic CDR3 during B cell development in
the BM and subsequent acquisition of additional basic residues during immune responses
leads to a progressive increase in ANA in SL-/- mice. These data suggest that the SL
probes CDR3 and that pre-B cells bearing μ-chains with basic amino acids in CDR3
either do not undergo expansion or are actively eliminated. The mechanism by which SL
selects against basic CDR3 remains to be determined. It is tempting to suggest that the
positively charged nature of the λ5-UR could be incompatible with positively charged
CDR3, resulting in poor pre-BCR formation. In summary, selection of μ-chains at the
pre-B cell stage is antigen independent, but SL is important for selecting against basic
amino acids in CDR3 that could potentially lead to autoreactivity in the periphery.
Cellular Locations of Pre-BCR Signaling
The general hypothesis is that signaling through the pre-BCR requires transit to the
plasma membrane, which is logical since most of the pre-B cell lines used in early
experiments were defined by surface pre-BCR expression [83, 247]. However, in
primary cells the surface expression of the pre-BCR is low and transient and often
undetectable [263]. One hypothesis is that the low level of surface pre-BCR is due to
rapid internalization in response to receptor crosslinking [257]. Alternatively, pre-BCR
may not transit all the way to the cell surface and instead signaling may occur within
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intracellular compartments. Consistent with this hypothesis, Guloglu and Roman showed
that forced localization of pre-BCR to the trans-golgi network (TGN) or the lysosome
still allowed for pre-BCR signaling and primary pre-B cell proliferation, whereas preBCR confined to the ER resulted in lower signaling and did not induce proliferation
[264]. These data suggest that pre-BCR signaling may occur both intracellularly and at
the cell surface. Intracellular pre-BCR signaling is plausible based on the ability of preBCR to signal through homotypic interactions [30, 249].
Pre-BCR Signaling
Proliferation
Proliferation at the pre-B cell stage results in 2-5 rounds of pre-B cell division,
meaning a single cell yields up to 64 daughter cells [30]. Each pre-B cell resulting from
this expansion will rearrange conventional light chain independently and produce a novel
BCR specificity. Proliferation signals downstream of pre-BCR signaling emanate from
pathways that synergize with IL-7R signaling [84]. Pre-BCR crosslinking activates the
receptor associated SRC family kinases, with Lyn being the most abundant in B-lineage
cells [265, 266]. Activated Lyn phosphorylates the immunoreceptor tyrosine-based
activation motifs (ITAMs) on the Igα/β signaling molecules associated with the pre-BCR
(Fig. 23). Syk (spleen tyrosine kinase) binds to phosphorylated ITAMs via SH2 domains
(protein sequences that recognize P-tyrosine residues) and proceeds to amplify BCR
signals by rapidly phosphorylating itself, other ITAMs, and downstream signaling
adaptors [267-270]. Syk-/- B cells exhibit a severe block at the pre-B cell stage resulting
from diminished pre-B cell proliferation [271-273].
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The main pathways by which Syk promotes pre-B cell proliferation are the
phosphoinositide 3 kinase (PI3K) pathway and the mitogen activated protein kinase
(MAPK) pathway [274]. Syk phosphorylates CD19 to form a membrane proximal
docking site for PI3K that in turn phosphorylates phosphatidylinositol-4,5 bisphosphate
(PIP2) yielding phosphatidylinositol-3,4,5 trisphosphate (PIP3) (Fig. 23 left) [275]. Two
kinases, PDK-1 (3-phosphoinositide dependent protein kinase-1) and Protein kinase B
(PKB) localize to PIP3 where PDK-1 activates PKB through phosphorylation. Active
PKB facilitates proliferation by blocking negative regulators of cell cycle progression
through phosphorylation, including members of the FOXO transcription factor family
that suppress cyclin D transcription and induce expression of cyclin dependent kinase
inhibitors (e.g. p27) [276, 277]. Maintaining low levels of active p27 and FOXO
transcription factors favors cell cycle progression from G0 to G1 [278].
Induction of proliferation by the transcription factors N-myc and C-myc is
downstream of the MAP kinase pathway, which is initiated in part by the scaffold protein
SLP-65 ((SH2 domain containing leukocyte protein 65 kDa) (a.k.a. BLNK or BASH))
(Fig. 23 right). SLP-65 is phosphorylated on multiple tyrosine residues by Syk and binds
a variety of effector proteins containing SH2 domains. SLP-65 is central to several pre-B
cell related processes with apparent functions in both initiation and termination of pre-B
cell proliferation [279, 280]. The MAPK adaptor protein Grb-2 binds to phosphorylated
SLP-65 and initiates the MAPK signaling pathway (SOS-RAS-RAF-MEK) with ERK
being a common point of pre-BCR and IL-7R signaling (Fig. 23 right) [281]. The
increased sensitivity to IL-7 induced proliferative signals in pre-B cells is attributed to
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synergy between IL-7 receptor and pre-BCR signaling resulting in upregulation of cell
cycle promoting genes (e.g. N-myc and C-myc) [84].
The importance of SLP-65 in attenuating pre-BCR signaling is evident in cases of preB cell leukemia in human and mice associated with defects in SLP-65 function [280].
SLP-65 blocks pre-B cell proliferation, in part, by inducing expression of the
transcription factor Aiolos, which suppresses λ5 expression limiting pre-BCR formation
and signaling [282]. Additionally, SLP-65 is hypothesized to downregulate PI3K
activity, perhaps through limiting pre-BCR formation, which results in attenuation of cell
cycle through increased nuclear localization of FOXO1; however, the exact mechanism
by which SLP-65 blocks PI3K activity remains to be elucidated [283].
Allelic Exclusion
Allelic exclusion ensures B cell clonality by only permitting expression of a single
IgH and IgL chain per cell. Allelic exclusion is maintained at the genomic level where
expression of a functional Ig chains chain feeds back to prevent rearrangement at the
other allele and requires signaling through membrane bound-μ [46]. Pre-B cell
proliferation and allelic exclusion are largely uncoupled, but both processes require
signaling through the pre-BCR. This idea is supported by the observation that some μchains transit to the cell surface independently of IgL (or SL) and mediate allelic
exclusion but not proliferation [57, 253]. The same observations were made in studies
using Dμ chains (IgH chains that contain a DJ-μ, but lack a VH region) that also signal for
allelic exclusion but do not induce proliferation [55, 284, 285]. This suggests that weak
signaling by μ-chains at the cell surface is sufficient for allelic exclusion and that strong
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pre-BCR crosslinking is required for proliferation. The weaker signaling requirement for
allelic exclusion, versus the stronger requirement for proliferation, may reflect a priority
of maintaining B cell clonality over expansion during B cell development.
Allelic exclusion is hypothesized to be downstream of Ca2+ signaling mediated by
Phospholipase-γ1 and 2 (PLCγ1/2). PLC-γ cleaves PIP2 into diacylglycerol (DAG) and
inositol-1,4,5-trisphosphate (IP3) (Fig. 24 right). DAG is a membrane bound
intermediate that recruits protein kinase C (PKC) to the plasma membrane, and IP3
triggers a surge in intracellular calcium from the ER that activates calcium responsive
proteins (such as PKC and NFAT). Genetic studies suggest no defect in allelic exclusion
when PLCγ2 alone is deleted in mice [286, 287]; however, PLCγ2-/-PLCγ1+/- mice do not
undergo allelic exclusion suggesting that a minimum level of signaling through PLCγ is
required [288]. SLP-65 and Bruton’s tyrosine kinase (BTK) are largely responsible for
PLCγ activation, although SLP-65 is not absolutely required due to partially redundant
functions of other proteins (e.g. LAT) [289]. Although allelic exclusion requires
signaling downstream of PLCγ, the exact mechanism by which Ca2+ mediates allelic
exclusion remains to be defined.
IgL Gene Rearrangement
Most studies of IgL gene rearrangement in mouse are centralized around the Igκ locus
due to the overwhelming bias of Igκ gene rearrangement versus Igλ [86]. Igκ gene
rearrangement requires simultaneous germline transcription of the κ locus and Rag1/2
gene expression. Germline transcription allows the Rag enzymes to access VL and JL
gene segments that otherwise would be sequestered in heterochromatin. The observation
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that μ-chain expression precedes Igκ germline transcripts suggested an ordered
rearrangement process in which μ-chain signaling instructs the rearrangement of IgL
genes [290].
The tight coupling of Rag gene expression with termination of pre-B cell proliferation
suggests that quiescence is important for IgL gene rearrangement [278, 291]. IRF-4 is
the major transcription factor implicated in the induction of Igκ germline transcription
[292, 293] and also contributes to pre-B cell quiescence by suppressing SL expression
through upregulation of Ikaros and Aiolos (Fig. 24 center). Additionally, reduction in
PI3Kinase activity simultaneously promotes Rag gene expression and quiescence through
increasing activity of FOXO transcription factors. FOXO1, as described earlier, is a
transcription factor that inhibits cell cycle progression and induces Rag1/2 gene
expression [277, 278]. The current model is that PI3K activity decreases as pre-B cell
proliferation terminates allowing active FOXO1 to enter the nucleus and maintain a
quiescent state while upregulating Rag1/2 gene expression (Fig. 24 left) [283]. Increased
Rag gene expression in combination with open Igκ loci allows for rearrangement of VL
and JL gene segments. Successful expression of the IgL chain marks the immature B cell
stage, and cells with non-self specificity will exit the BM and transition to maturity.
B cell Development and Selection in Mutant ali/ali Rabbits
Discovery of the ali/ali Mutant Rabbit
The mutant ali/ali rabbit was discovered 25 years ago through the study of VH
allotypes, VHa and VHn [294]. The majority of serum Ig in wt rabbits is VHa+ and the
remaining Ig is VHn+. There are three VHa subtypes (a1, a2, a3) that are inherited in a
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Mendelian fashion, allowing for rabbits with homozygous allotypes (e.g. a2/a2), or
mixed allotypes (e.g. a1/a3; a1/a2; a3/a3 etc.) [295]. The ali/ali rabbit is homozygous
for a variant of the a2 allele called “ali”, and young ali/ali rabbits have normal levels of
total serum Ig, but unlike wt rabbits, most of the Ig is VHn+ [294].
The serum concentration of VHa+-Ig and frequency of VHa+ B cells in ali/ali rabbits
increases with age (Fig. 25) and eventually reaches that of wt rabbits [164, 294]. The
ali/ali phenotype is recessive as evidenced by ali/a1 heterozygous rabbits having normal
levels of VHa+-Ig, mostly contributed by the a1 allele. This observation, in conjunction
with the detectable levels of VHa-Ig in serum of ali/ali rabbits, suggested that the genes
encoding the a2 allotype are intact and that the ali mutation was due to a cis-regulatory
element that dampened but did not totally ablate a2 expression [294]. This was a
reasonable hypothesis for the delay in accumulation, but not total absence, of VHa-Ig in
the serum, especially since no obvious abnormalities in the ali Igh locus were detected at
that time.
Molecular Basis for Decreased VHa+-Ig in ali/ali Rabbits
A seminal study by Knight and Becker simultaneously elucidated the mechanism for
VHa allotype inheritance in wt rabbits and explained the paucity of VHa+-Ig in the serum
of young ali/ali rabbits. They found that wt rabbits utilize the 3’ most VH gene, VH1, in
the majority of VDJ gene rearrangements and that VH1 encodes the VHa allotypes (a1, a2,
a3) explaining their Mendelian inheritance. They also found that the ali allele has a ~10
kb deletion that encompasses the a2-encoding VH1 gene [16]. The absence of VH1
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explained the low level of VHa -Ig in the serum of young ali/ali rabbits; however, the
mechanism for the age dependent increase in VHa+-Ig remained to be determined.
Mechanism for VHa to VHn Allotype Switch in ali/ali Rabbits
The VHn+- to VHa+-Ig switch in ali/ali rabbits begins in adolescence and continues into
adulthood. During this time, B-lymphopoiesis begins to decline and eventually stops
[151]; therefore, the switch likely occurs within the pre-existing B cell compartment in
the periphery rather than through generation of new VHa+ B cells in BM. There are two
non-mutually exclusive hypotheses that explain the switch from VHn+ to VHa+ B cells in
the periphery of ali/ali rabbits. The first is that VHa+ B cells are positively selected
through expansion and/or survival in the periphery, and the second is that VHn+ B cells
die by neglect or are actively deleted.
Previous studies demonstrated that GALT and the intestinal microbiota were required
for expansion [170] and diversification [169] of the primary B cell repertoire in rabbit
and led to the hypothesis that GALT was also required for the preferential selection of
VHa+ B cells. Consistent with this hypothesis, surgical removal of GALT (appendix,
Peyer’s patches, and sacculus rotoundus) in ali/ali rabbits prevented the VHn to VHa
allotype switch, suggesting that these tissues and likely the intestinal bacteria were
required (Fig 26, right). Subsequent studies using the ali/ali GALT-less ligated appendix
model, in which the appendix is kept sterile through surgical ligation at birth and all other
GALT is removed, found that injection of total commensal bacteria into sterile
appendices allowed for the VHn to VHa switch, whereas injection of PBS did not (Fig. 26)
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[164]. These data suggested that both GALT and the intestinal microbiota are required for
the selection of VHa+ over VHn+ B cells.
VHa+ and VHn+ B cells are both found in the proliferating region of B cell follicles in
GALT, suggesting that there is likely no difference in the proliferative capacity between
VHa+ and VHn+ B cells (Knight lab un-published). The Mage lab reported increased
apoptosis of VHn+ B cells within GALT suggesting that these cells are dying of neglect or
are actively deleted [296]. The current hypothesis is that VHa+ B cells are positively
selected through stimulation of the BCR by superantigen-like molecules that bind to a
site formed by VHa-allotype residues and not VHn-allotype residues (Fig. 14) [164, 297].
The source of superantigens is currently unknown, although they are presumed to be
bacterially derived or bacterially induced molecules based on the requirement of both
GALT and the intestinal microbiota for positive selection of VHa+ B cells [167].
The Enigma of B cell Development in ali/ali BM
Ali/ali rabbits have normal levels of serum Ig; however, most of it is VHn+. The
simplest explanation for the increased VHn+-Ig and VHn+ B cells in young ali/ali rabbits is
that VHn gene rearrangement (VHx, VHy, VHz) increases in the absence of VH1 and that a
low but detectable level of VHa+-Ig is due to limited rearrangement of other VHaencoding genes (VH4, VH7, VH9). Studies by Zhu et al. showed this was not case and that
the predominantly rearranged VH gene during ali/ali B cell development is VH4, which
like VH1, encodes the a-allotype (Fig. 27)[298, 299]. Although VH4 is predominantly
rearranged, most of these cells are lost during early B cell development. Therefore, the
decreased frequency of VHa+ B cells and lower level of VHa+-Ig in ali/ali rabbits is not
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due to infrequent VHa-gene rearrangement but rather due to the loss of VHa B cells
during development in BM. The enigma is that while VHa+-B cells are lost during
development in BM, cells using these same genes are expanded in the periphery. How
can ali/ali rabbits negatively select VHa-encoding B-lineage cells in the BM, only to later
expand such cells in GALT?
Remaining Questions Regarding ali/ali B cell Development in BM
Prior to my dissertation work, it was known that VH4 (VHa-encoding) was
predominantly rearranged during B cell development in ali/ali rabbits and that most of
the VH4-utilizing B-lineage cells were lost during development in the BM (Fig. 28, left).
In the periphery, the few VHa+ B cells that survive development are positively selected,
and the VHn+ cells are lost though mechanisms that require the GALT and intestinal
microbiota (Fig. 28, right). VH4-μ chains appear functional in mature B cells and yet are
problematic for early B cell development. The focus of my dissertation work is to
determine the mechanism(s) by which the VH4-utilizing B-linage cells are negatively
selected in the BM of ali/ali rabbits, and the following sections describe my findings and
discuss the contribution of my work.
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CHAPTER TWO
MATERIALS AND METHODS
Rabbits
New Zealand White rabbits were from the colony maintained by Katherine L. Knight
at Loyola University Chicago. Mutant ali/ali rabbits were progeny of rabbits originally
described by Kelus and Weiss [294]. Studies were approved by the Institutional Animal
Care and Use Committee of Loyola University Chicago.
Flow Cytometry
All staining for flow cytometry was performed on ice, unless otherwise specified, with
minimal light exposure. Antibodies used for flow cytometry experiments are listed in
Table 2. All samples were washed twice with 0.5 ml FACS buffer between staining
steps. Viability was determined using Live/Dead® Aqua from Invitrogen Molecular
ProbesTM (Carlsbad, CA) according to the manufacturer’s instructions or by propidium
iodide staining (1mg/ml stock used at 1:100). Fixation and permeabilization was
performed with BD Cytofix/CytopermTM, unless otherwise noted. All flow cytometric
data were collected on FACSCantoTMI or II; cell sorting was performed on the
FACSAriaTM cell sorter (BD Biosciences; San Jose, CA) and analyzed using FlowJo
software (Tree Star; Ashland, OR).
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Cell Lines
Phoenix-ECO
Phoenix-ECO cells are a human epithelial kidney-293-T derivative used to make
ecotropic viruses that infect rodent cells (Dr. G. Nolan, Stanford University, Palo Alto,
CA). Phoenix-ECO cells stably express the gag, pol and env genes to generate
transducing particles that package genes flanked by Moloney murine leukemia virus
(MuLV) 5’ and 3’ LTRs. This system does not produce replication competent viruses.
Phoenix-Eco cells were grown in DMEM+10% FCS+Pen/Strep.
OP9-GFP
OP9-GFP cells are a mouse BM stromal cell line that stably expresses GFP and
supports in vitro differentiation of B-lineage cells from stem cell precursors [300]. These
cells were used for in vitro cultivation of rabbit B lineage cells described below. (*Note:
Working stocks of OP9 stroma were made and used for individual experiments.
Overpassaging these cells or letting them become too confluent reduced their ability to
support B lymphopoiesis.) OP9 stroma was grown in α-mem+20% FCS+Pen/Strep.
38B9
38B9 is a mouse Pre-B cell line that lacks productive IgH chain rearrangements and
expresses the surrogate light chain [83]. These cells were a gift from Fritz Melchers and
are used for testing μ-chain pairing with SL as described below. 38B9 cells were grown
in DMEM+10% FCS+Pen/Strep.
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Table 1. Abbreviations used in Materials and Methods
Abbreviation

Full Name

Company

City/State

FCS

Fetal Calf Serum

Atlanta
Biologicals

Lawrenceville,
GA

FACS
Buffer

PBS+5% FCS

X

x

Invitrogen
Gibco®

Carlsbad, CA

Invitrogen
Gibco®

Carlsbad, CA

Invitrogen
Gibco®

Carlsbad, CA

DMEM

Α-mem
Pen/Strep

Dulbecco’s
Modified Eagle
Medium
Minimal
Essential
Medium
Penicillin
Streptomycin

BSA

Bovine Serum
Albumin

Fisher
Scientific

Pittsburgh, PA

PEI

Polyethylenimine

Polysciences
Inc.

Warrington,
PA

FACS

Fluorescence
Activated Cell
Sorting

X

x

bio
SAV

biotin
strepavidin

X
X

x
X
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Table 2. Antibodies Used for Flow Cytometry
Host
Clone
Species Number

Cat. # [Stock]

Working
Dilution

BD*
Biosciences

5559
35

prediluted

20µl/rxn

NA

BD*
Biosciences

5511
34

prediluted

20µl/rxn

ms

367.2bio

BD*
Biosciences

5509
38

0.5
mg/ml

1:500

hybridoma
supe.

ms

367.2

KLK lab

X

X

3µ/rxn

PE

ms

I1s0722

BD*
Biosciences

5585
29

prediluted

20µl/rxn

biotin

rat

SL-156BD*
bio
Biosciences

5518
63

0.5
mg/ml

1:25

FitC

rb

NA

BD*
Biosciences

516865
4

prediluted

20µl/rxn

PE

rat

187.1

BD*
Biosciences

5599
40

0.2
mg/ml

1:50

FitC

gt
(Fab'2)

NA

Jackson
ImmunoResearch†

115097003

1.7
mg/ml

1:100

unlabeled

gt
(Fab'2)

NA

Jackson
ImmunoResearch†

109006127

1.2
mg/ml

1:50

FitC

rb
(Fab)

NA

Jackson
ImmunoResearch†

305097003

1.8
mg/ml

1:50

KLK lab

KLK
lab

1
mg/ml

1:50

Antigen

Label

human
CD79a

PE

rb

NA

human
CD79a

APC

rb

rabbit-µ

biotin

rabbit-µ
human
Syk-PY348
mouse
preBCRhuman
active
Caspase3
ms-Igκ
mouse
H+L
human
IgM
H+L
Gt IgG

Rabbit
Ig
rb
biotin
R302-1
allotype
(a1/a3)
a2
*San Diego, CA; †West Grove, PA

Company
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Table 2. Continued
Host
Clone
Species Number

Antigen

Label

mouse
IgM

PE-Cy7

Rt

II/41

eBioscience*

mouse
IgM

PE

Rt

II/41

eBioscience*

X

strepavidin
APC

x

NA

Jackson
ImmunoResearch†

X

strepavidin
PE -CY7

x

NA

X

strepavidinDTAF

x

NA

strepavidin
x
NA
APC-Cy7
*San Diego, CA; †West Grove, PA
X

Company

BD*
Biosciences
Jackson
ImmunoResearch†
BD*
Biosciences

[Stock]

Working
Dilution

0.2
mg/ml

1:50

0.2
mg/ml

1:500

0.5
mg/ml

1:50

557598

0.2
mg/ml

1:50

016010084

1.8
mg/ml

1:50

Cat. #
25579082
12579083
016130084

554063 0.2mg/ml

1:50

Preparation of Rabbit Splenocytes
Single cell suspension of rabbit spleen was generated by gently mashing small pieces
of spleen between two frosted slides in FACS buffer. Cell suspensions were strained into
a 50 cc conical tube using a 100 μm strainer and pelleted. Hypotonic red blood cell lysis
was performed by adding 10 ml of 0.1x PBS for 20 seconds followed by addition of 10
ml of 2x PBS and 30ml FACS buffer. Cells were pelleted and washed once with 20 ml
FACS buffer. The pellet was resuspended in 10 ml media (or FACS buffer), passed
through a 100 μm strainer, and live cells were counted by trypan blue exclusion.
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Preparation of Rabbit Bone Marrow Cells
Single cell suspensions of total BM were generated by flushing rabbit femurs with 10
ml of ice cold medium (α-MEM+20% FCS+Pen/Strep) and multiple passes through a 16
gauge needle. Cell suspensions were strained into 50 cc conical tubes using 100 μm
strainers and pelleted. Supernatant was removed and the red blood cells in the pellet
were lysed using 10 ml of sterile 0.85% NH4Cl per femur for 4 minutes at room
temperature, followed by addition of 40 ml cold medium to stop cell lysis. Cells were
pelleted, washed with 10 ml cold medium and re-suspended in a final volume of 10-20 ml
of cold medium. If needed, cells were passed a second time through a 100 μm strainer
and live cells were counted using trypan blue exclusion.
OP9 Co-cultures
Murine OP9-GFP stromal cells were seeded at 7 x 104 cells/100 mm dish in 10 ml
medium (α-MEM+20% FCS+Pen/Strep), and 16-24 hr later, 2.5 x 106 total BM
mononuclear cells from wt or ali/ali rabbits were added to each dish in 10 ml of medium
(20 ml total volume/plate) and cultured with 10ng/ml recombinant human IL-7
(PreproTech Inc; Rocky Hill, NJ). (IL-7 reconstitution: To avoid multiple freeze thaw
cycles, recombinant human-IL-7 was resuspended in 40% glycerol which allows the
cytokine to be stored at -20ºC without freezing. The IL-7 stock was prepared at a
concentration of 200ng/μl and 1μl of the IL-7 stock was added per plate (20ml) yielding a
final concentration of 10 ng/ml.) On day 4, each dish received an additional 200 ng of
human IL-7 and 10 ml of medium. After 7 days in culture, non-adherent cells were
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harvested, passed through a 100 μm strainer and the number of live cells was determined
by trypan blue exclusion. The phenotype of these cells was determined using flow
cytometry. ~70-90% of lymphocyte cells were pro-B (CD79a+ cyto-μneg) with almost no
pre-B cells (CD79a+cyto-μ+) (Fig 29). Equal numbers (7 x 105) of ali/ali or wt pro-B
cells were seeded per well in 24 well plates with fresh OP9-GFP stroma (12 x 103 OP9
stromal cells were seeded 16-24 hours prior) in the absence of IL-7 and allowed to
differentiate to pre-B and immature B cell stages.
Carboxyfluorescein Succinimidyl Ester (CFSE) Labeling
The stock vial of CFSE from the CellTRACETM CFSE Cell Proliferation Kit
(Invitrogen Molecular ProbesTM; Carlsbad, CA) was resuspended to 0.5 mM in DMSO.
Cells were pelleted in 50 cc conical tubes and washed briefly in 10-20 ml of
1xPBS+0.1%BSA (depending on pellet size). Cells were resuspended at 1 x106 cells/ml
in pre-warmed (37◦C) 1xPBS +0.1% BSA. 0.5 μl of CFSE stock [0.5 mM] was added per
ml of cells and incubated in the dark using the 37◦C water bath for 15 minutes. To
quench the CFSE labeling reaction, 5 volumes of ice cold medium+10-20% FCS was
added and the cells were incubated on ice for 5 minutes. Cells were washed twice with
20 ml medium containing 10-20% FCS and resuspended in a low volume for cell
counting by trypan blue exclusion. Aliquots of labeled and unlabeled cells were fixed at
time zero using cytofix/cytoperm for compensation and determining efficiency of
labeling. Figure 30 shows representative time zero plots for CFSE labeling.

90

91
Fluorescent Bead Based Cell Counting by Flow Cytometry
The ratio of pre-B to pro-B numbers in these cultures was determined by adding an
equal number (1.5 x 105) of 3µm Fluoresbrite® YG Microsphere beads (Polysciences;
Warrington, PA) to each sample. Total events were collected using a stopping gate of
3 x 104 YG Microsphere beads, and the number of live pre-B and pro-B cells in the
lymphocyte gate was used to generate the pre-B to pro-B ratio (Fig. 31). Protocol was
modified from Montes et al. [301].
α-Human-Phospho-Syk Crossreactivity in Stimulated Rabbit Splenocytes
Splenocytes were prepared as described above. 0.5 x 106 cells were added to FACS
tubes in a volume of 100μl 1xPBS+1%FCS. Surface Ig was crosslinked using 8μg/ml
goat (Fab’)2 anti-rabbit IgG H+L (Jackson Immuno Research, West Grove, PA) followed
by incubation in the 37ºC water bath for 10 minutes. Cells were fixed using 1 ml prewarmed (37ºC) PhosflowTM Lyse/Fix BD (Pharmingen; San Diego, CA) with continued
incubation at 37ºC for 10 minutes. Cells were pelleted and washed with 1 ml of
1xPBS+1%FCS (room temperature). The pellet was resuspended by gentle flicking and
permeabilized using cold (-20ºC) PhosflowTM Perm Buffer II (BD Pharmingen; San
Diego, CA) and incubated on ice for 20-30 minutes. (Note: Perm Buffer II was added
slowly with gentle vortexing.) Cells were pelleted and washed in 2ml ice cold
1xPBS+1% FCS. Cells were stained at room temperature using ms α-human-PhosphoSyk-Y348-PE and α-human-CD79a-APC antibodies and analyzed by flow cytometry
(Fig. 32).
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Phospho-Syk Analysis in Rabbit Pro-B and Pre-B cells Derived From OP9 Cultures
In vitro derived rabbit pro-B and pre-B cells were derived from OP9 co-cultures as
described above. Four to five days after pro-B cell transfer to fresh OP9 stroma, the nonadherent cells were harvested and passed through a 100 μm strainer, pelleted at room
temperature and resuspended in 100 μl 1xPBS+1%FCS. These cells were incubated in
the 37ºC water bath for 10 minutes but did not receive an anti-Ig stimulus. Fixation and
permeabilization were carried out as described above for splenocytes. Cells were stained
with α-human-Phospho-Syk-Y348-PE, α-human-CD79a-APC and α-rabbit-μ (367bio+SAV-DTAF). Stained cells were analyzed by flow cytometry.
PCR Amplification and Sequencing of VDJ Genes
Pro-B, pre-B and immature-B cells from ali/ali rabbit BM cultures were bulk sorted
(1000 cells/well) between 0-7 days after Pro-B cell transfer to fresh OP9 stroma, as
described above. Gating strategy for sorting of B-lineage populations is depicted in
Figure 33. VDJ gene segments were PCR-amplified using the forward pan VH leader
primer (GR1) and reverse rabbit JH primer (GR2)(Table 3). PCR products were cloned
into pGEM®-T-Easy Vector (Promega, Madison, WI), and the nucleotide sequences were
determined in one orientation using a T7 or SP6 promoter.
Modification of pBMN-I-GFP Vector to Destroy SalI and HindIII Sites
The retroviral vector pBMN-I-GFP is a bi-cistronic reporter construct. The gene of
interest is cloned upstream of an internal ribosomal entry site (IRES) that allows for
translation of the downstream GFP (Fig. 34). The Sp6-Ldr-Rb-VDJ-msCμ encodes a
chimeric IgH chain comprised of the mouse Sp6-leader sequence, a rabbit VDJ-domain
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and mouse Cμ. There is a SalI restriction site 5’ of VH and a HindIII site 3’ of JH that
allow for easy interchanging of VDJH cassettes (Fig. 35). In order to maintain the unique
SalI and HindIII sites in the H chain, the SalI and HindIII sites in the vector backbone
needed to be destroyed. To eliminate these restriction sites in pBMN-I-GFP, the 5’
overhangs of linearized vectors cut with SalI or HindIII were filled using Klenow
polymerase (New England BioLabs Inc, Ipswich, MA) at 37ºC for 30 minutes. Ten ng of
agarose gel purified vector was used for intramolecular blunt end ligation followed by
electroporation into DH10β E.coli. and plating on LB/Amp (100 μg/ml). Clones were
screened for correct vector size and loss of SalI and HindIII sites.
PCR Amplification and Cloning of Sp6-Ldr-Rb-VDJ-msCμ into
pBMN-I-GFP SalI- HindIIISp6-Ldr-msCμ encodes a mouse μ-chain with a rabbit VDJH region (Fig. 35). This
chimeric IgH chain was PCR amplified from the pELVC vector using Taq Polymerase
(Sigma, St. Louis. MO) and primers GR57 and GR58 (Table 3). The 1.8 kb IgH-chain
(Sp6-Ldr-msCμ) was cloned into pGEM®-T-Easy Vector (Promega, Madison, WI) and
sequenced using T7, Sp6 and internal primers GR61 and GR62 (Table 3). The Sp6-LdrmsCμ was cloned from pGEM-T-Easy into pBMN-I-GFP SalI-HindIII- using NotI.
Clones with the H chain insert in the forward orientation were tested for the ability to
generate transducing virus (described below) that expressed the chimeric IgH chain and
GFP. This vector is termed pBMN-I-GFP Sp6-Cμ.
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Table 3. Oligonucleotide Primers
Primer
#

Primer Name

Primer Sequence

Enzyme
Site

Tm
(ºC)

GR1

os Rb LdrRI

5'-GGCTGAATTCGCTTC
TCCTGGTCGCTGTG-3'

EcoRI

66

5'-GGATCCCTGGTCACC
BamHI
64
GTCTCCTCA-3'
5'-CAGTGTGTCGACGTT
GR48
os VH4 pELVC
SalI
67
GAGGAGTCCAGGGGA 3'
5'-CAGTGTGTCGACGTG
GR49
os VH1-a2 pELVC
SalI
67
AAGGAGTCCGAGGGA-3'
5'-TTGGGAAGCTTTGGC
GR50
oa raJH msCµ1
TCTCCGAGGAGACGGT
HindIII
69
GAC-3'
5'-GTACTGGCGGCCGCT
GR57
oa msCµ4-tga NotI
CACTTCACCTTGAACAG
NotI
68
AG-3'
ms IgH Sp6 fwd Xho 5'-GACTCGAGATGGGAT
GR58
XhoI
64
I
GGAGCCGGATC-3
5'-GGGTATCAGAACCTT
GR61
ms Cµ Forward Seq
N.A.
54
CCCAA-3
5'-CCTCTGTGGTGAAGG
GR62
ms Cµ Reverse Seq
N.A.
55
CAGAT-3'
5'-AAATTCGAAT TCCTG
5' pBMN-I-GFP SacII CAGGCCTCGAGGGCCG
mutated
GR87
76
mutagenesis
GCGCGTTGCGGCCGCTA SacII site
-3'
5'-GTCCGCCAGGCTCCC
5' VH4-Y47W
GGGAACGGGCTGGAAT
GR88
N.A.
75
mutagenesis
GGATCGGAACCATTGG
T-3'
5'-ACTACTACCAATGGT
3' VH4-Y47W
TCCGATCCATTCCAGC
GR89
N.A.
72
mutagenesis
CCGTTCCCGGGAGCCTG
G-3’
yellow highlight = restriction enzyme sites; turquoise highlight = mutations in restriction
enzyme site; mixed bases: S = C or G; K = G or T; N.A.= Not Applicable
GR2

oa Rev JH BamHI
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Table 3. Oligonucleotide Primers (continued)
Primer
#

Primer Name

Primer Sequence

Enzyme
Site

Tm
(ºC)

5'-CAGTGTGTCGACTTG
GR91 5' SalI VH1-a3 primer GAGGAGTCCGGGGGASalI
69
3'
5'-TGGGTCCGCCAGGC
5' VH1-a2 W47Y
GR92
TCCCGGGAACGGGCTG
N.A.
76
mutagenesis
GAATACATCGGAGCC-3'
5'-ACCAATGGCTCCGAT
3' VH1-a2 W47Y
GR93
GTATTCCAGCCCGTTCC
N.A.
75
mutagenesis
CGGGAGCCTGGCG-3'
5'- GTCCGCCAGGCTCCC
5' VH4- Y47F
GGGAACGGGCTGGAAT
GR94
N.A.
75
mutagenesis
TCATCGGAACCATTGG
T-3'
5'-ACTACTACCAATGGT
3' VH4- Y47F
TCCGATGAATTCCAGC
GR95
N.A.
71
mutagenesis
CCGTTCCCGGGAGCCT
G-3'
5'-CAGTGTGTCGACGAG
GR97
5' Rabbit VHY and Z
SalI
68
CASTCCGGAGGAGG-3
5'-GGGAACGGGCTGGA
5' VH1-a2 Y47W
GR124
ATACATCGGAACCATC
N.A.
69
+A50T
GGTAGTAGTGGTAGC-3'
5'-GTATGCGCTACCACT
3' VH1-a2 Y47W
GR125
ACTACCGATGGTTCCG
N.A.
68
+A50T
ATGTATTCCAGCCC-3'
5'Ldros-Rb Ldr outside
5'-ACAGACGCTCACCAT
N.A.
57
out
primer
GGAG-3'
3'VDJoa-Rb JH outside
5'-AGTTGAGTAGGAGA
N.A.
48
out
primer
GAGA-3'
5'Ldros-Rb Ldr inside
5'-CTGGTCGTGCTCAAA
N.A.
50
in
primer
G-3'
3'VDJ5'-GAGTTGGCAAGGACT
oa-Rb JH inside primer
N.A.
53
in
CAC-3'
yellow highlight = restriction enzyme sites; turquoise highlight = mutations in restriction
enzyme site; mixed bases: S = C or G; K = G or T
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Site Directed Mutagenesis of VH genes
VH-DJ genes (VH1 and VH4) were subjected to site-directed mutagenesis using whole
plasmid amplification in which two large overlapping primers are used in conjunction
with a high fidelity polymerase to generate mutations. The VDJ regions were subcloned
into the pGEM-T-Easy vector to make the amplification step easier (pGEMT-Easy is
~3kb smaller than pBMN-I-GFP which allows for more efficient plasmid amplification).
Overlapping ~45 nt primers ((VH4-Y47W, GR88-89; VH1-a2 W47Y, GR92-93; VH4Y47F, GR94-95)(primers in Table 3)) encoding the respective mutation were used to
PCR amplify 50 ng of the target pGEM-T-Easy-SalI-VDJ-HindIII vector using
PfuTurbo® polymerase (Stratagene, Lost Pines, TX). The amplification process
generated un-methylated copies of the template DNA with the specified mutations.
Addition of DpnI (1 unit/rxn) degrades the methylated template DNA and leaves the unmethylated Pfu amplified DNA intact. After DpnI digestion, 1ul of the PCR reaction was
transformed into E. coli and plated on LB-Ampicillin (100ug/ml) plates. Control samples
with the same amount of template DNA, but lacking Pfu polymerase, were also treated
with DpnI and typically yielded zero colonies. Single colonies from site-directed
transformants were expanded in liquid LB-Ampicillin (100ug/ml) cultures and the
plasmid DNA was purified and sequenced using T7 or SP6 primers. These mutated VDJ
regions were cloned into the pBMN-I-GFP Sp6-Ldr-Cμ* vector described in the next
section.
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Generating the pBMN-I-GFP Sp6-Cμ* Vector
Exchange of DJH regions between germline and site-directed mutant VH4 or VH1
genes in Sp6-Cμ was accomplished by double digest with SacII and HindIII allowing us
to test the effects of different CDR3 regions on surrogate light chain pairing (Fig. 35).
The SacII site is at the 3’ end of VH4 and VH1 and the HindIII site is 3’ of JH. In order to
utilize the SacII site in VH for the exchange of DJH regions, the other SacII site in the
vector backbone (upstream of Sp6) needed to be mutated. Site directed mutagenesis was
used to destroy the SacII site 5’ of the Sp6-Leader.
Sp6 Ldr-Cμ was amplified from pBMN-I-GFP using PfuTurbo® polymerase
(Stragene, Lost Pines, TX) and the following primers (also in Table 3): the forward
primer introduced a mutation into SacII site 5’ of Sp6-leader (GR87) and the reverse
primer anneals to the 3’ end of mouse Cμ4 (GR57). The 1.8 kb product was cloned into
pGEM®-T-Easy Vector (Promega, Madison, WI) and loss of the 5’SacII site was
confirmed by DNA sequencing. The SacII- Sp6-Cμ insert was cloned into pBMN-I-GFP
SalI- HindIII- using EcoRI. A clone with the H chain in the forward orientation was
identified and used for all subsequent experiments. This vector is called pBMN-I-GFP
Sp6-Cmu* (the * signifies mutated SalI, HindIII, and SacII sites in this construct). VH1,
VH4, and VHy gene segments were also cloned into this vector using the forward primers
(GR48, GR49, and GR97, respectively) with the reverse primer GR50. Figure 35
depicts the final vector that allows for cloning of complete VDJ gene cassettes into the
SalI and HindIII sites or for exchange of DJH segments using SacII and HindIII.
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This vector was used to generate the ecotropic retrovirus for transduction of 38B9 cells
described below.
Retrovirus Production and 38B9 Cell Transduction
Germline or mutant VDJ genes were PCR-amplified from bulk sorted ali/ali or wt
rabbit pre-B cells derived from OP9 cultures or from mature splenic B cells using the
following 5’ SalI VH-gene specific primers VH4 (GR48), VH1-a2 (GR49), VHy/z (GR97)
with the reverse primer 3’ rabbit-JH mouse Cμm –HindIII (GR50). These VDJ regions
were cloned into pBMN-I-GFP Sp6-Cμ* vector and used to generate transducing
retroviruses in Phoenix-ECO cells. 5 x 106 Phoenix-ECO cells were seeded in 100 mm
dishes and transfected using PEI at a ratio of 2.25μg PEI (Polysciences; Warrington,
PA)/μg DNA. Media was replaced 12-16 hours later and virus containing medium was
harvested 48 hours after initial transfection.
38B9 pre-B cells were transduced by spinoculating 300μl of virus buffered with
10mM Hepes onto 7 x 104 38B9 cells/well (48 well plate) at 1200 x g for 1.5 hours at
30ºC. One-half of the medium was replaced at 4 and 16 hours following transduction.
GFP+ cells were FAC-sorted and analyzed by flow cytometry for expression of surface μ
(rt α-mouse μ PE-Cy7), surface pre-BCR (SL156-bio/SAV-APC), and cytoplasmic μ (rt
α-mouse μ PE). 38B9 cells were tested pre- and post-transduction for the expression of
endogenous-µ and Igκ expression and Igκ expression was not detected in any of the
cultures. All cells were grown in DMEM+10% FCS+Pen/Strep.

104
Generation of Human Igκ Transgenic ali/ali Rabbits
The human-Igκ transgene was made by Roche Diagnostics using the BAC clone
179L1 [302] coding for parts of the rabbit Igκ1 locus and was modified by homologous
recombination in E. coli. The rabbit Cκ constant gene was exchanged against the human
Cκ1 gene and a rearranged human VJκ with rabbit κ promoter and was inserted into the
Jκ region. The linearized BAC was used for transgenesis. Founder lines were
backcrossed onto the Bas background [303]. The peripheral blood mononuclear cells
(PBMC) from human-Igκ ali/ali rabbits and age-matched non-transgenic controls were
prepared using Lympholyte® (Cedarlane, Brulington, NC) and provided by J. Platzer
(TR-T~Penzberg; Roche Diagnostics GmbH). PBMCs were frozen and sent to Loyola
University Medical Center on dry ice and were immediately transferred to liquid nitrogen
for storage. Cells were washed with FACS buffer to remove DMSO upon thawing and
stained for surface-μ (367-supe/Gt-Fab α-msIgG-FitC) and VH-a2 allotype (α-a2bio/SAV-APC). ~80% of peripheral blood B cells in hu-Igκ-tg ali/ali rabbits expressed
hu-Igκ on their surface (Fig. 36).
PCR Amplification and Sequencing of VDJ Genes From Single Cells
The VDJ genes of single IgM+allotype a2+ peripheral blood B cells of hu-Igκ
transgenic ali/ali rabbits were amplified using nested PCR. Single cells were sorted into
96-well plates containing 30 μl of 1x JumpStart™ Taq buffer (includes 15 μM MgCl2)
(Sigma-Aldrich®, St. Louis, MO) + 10 μg proteinase K (Gibco®/Invitrogen, Carlsbad,
CA) and incubated at 37ºC for 2.5 hours. Plates were briefly centrifuged and the liquid
was transferred to individual PCR tubes. Proteinase K was heat inactivated by incubation
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for 10 minutes at 98ºC. A 20μl master mix containing 1x JumpStart™ PCR buffer, 1.25
units of JumpStart™ Taq, dNTP (final concentration of 200 μM) and outside VDJ
primers (5’Ldr-out and 3’VDJ-out (final concentration of 200 nM for each primer)) was
added to each reaction, yielding a final volume of 50 μl. Each sample underwent 40
cycles of PCR and 2 μl of the first round products were used for an additional 40 cycles
of PCR with the inside VDJ primers (5’Ldr-in and 3’VDJ-in). PCR products from the
second round were cloned into pGEM®-T-Easy Vector (Promega, Madison, WI) and
sequenced in one orientation using an SP6 or T7 promoter.
Crystal Structure Analysis and Images
All 3-dimensional crystal structure images were downloaded from the RCSB protein
Data Bank (http://www.rcsb.org/pdb/home/home.do) and are referenced in the figures by
their four character PDB ID. These structures were viewed and analyzed using
DeepView/Swiss- PdbViewer v4.0 (Swiss Institute of Bioinformatics) and PyMOL™
(DeLano Scientific).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism v5.03 (GraphPad Software,
La Jolla, CA) or using the VassarStats Website for Statistical Computation.
(http://faculty.vassar.edu/lowry/VassarStats.html)

CHAPTER THREE
RESULTS: IDENTIFYING THE MECHANISM FOR PRE-B CELL SELECTION IN
ALI/ALI MUTANT RABBITS
The mutant ali/ali rabbit provides a model system for understanding B cell selection
during development in the BM and B cell maintenance in the periphery. Ali/ali rabbits
predominantly rearrange the 3’ most VH gene, VH4, which is generally not permissive for
B cell development in the BM [298]. Only few VH4-utilizing B cells survive
development and enter into the periphery where remarkably, they undergo expansion
with age and become the dominant cell type. The expansion of VH4-utilizing B cells
requires the GALT and intestinal microbiota [164]. Further, this expansion occurs at a
time in which B-lymphopoiesis in the BM has slowed considerably or completely
stopped [151], making it unlikely that the increase in peripheral VH4-utilizing B cells is
due to a sudden surge of VH4-utilizing B lymphocytes from the BM. Although much is
known about the timing and mechanisms of VH4-utilizing B cell expansion in GALT, we
still do not understand the mechanism(s) mediating negative selection of VH4-utilizing Blineage cells in the BM.
Previous studies from our lab, and others, have demonstrated that VH4 is the
predominantly rearranged gene during B cell development and is readily detected in the
non-productive VDJ genes of pro-B cells. However, VH4-utilization is virtually
undetectable at the pre-B cell stage, suggesting that these cells are lost soon after VDJ
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gene rearrangement [298]. Our interest has been in identifying the stage and
mechanism(s) for loss of VH4-utilizing B-lineage cells during development in the BM.
That VH4-DJ gene rearrangements are readily detectable in ali/ali pro-B cells but are
undetectable at the pre-B cell stage led us to hypothesize that VH4-utilizing cells are lost
between the pro-B to pre-B cell transition. At this stage, the productive VH to DJ gene
rearrangements are expressed as µ-chains and tested for functionality through pairing
with SL and signaling through the pre-BCR. Therefore, loss of VH4-utilizing cells is
likely due to one of the following possibilities: The first is that VH4-μ chains are
inherently autoreactive, and when expressed as a pre-BCR on the cell surface, they
interact with autoantigens in the BM environment leading to strong pre-BCR signals and
clonal deletion (Fig. 37A). The second possibility is that VH4-μ chains are unable to
form signal competent pre-BCR and fail to expand at the pre-B cell stage and/or die of
neglect (Fig. 37B) [304-306]. We favor the latter possibility because several studies in
mouse have identified μ-chains that do not pair with SL and result in arrest of B cell
development, and no studies to date have identified a strong pre-BCR stimulus as
grounds for pre-B cell deletion during B cell development in BM. Nevertheless, these
two possibilities exist, and I used an in vitro culture system to test if loss of VH4-utilizing
cells requires the rabbit BM environment.
In Vitro Development of B-lineage Cells from BM of ali/ali Rabbits
To determine if VH4-utilizing pre-B cell loss can be recapitulated in vitro, I cultured
the BM of ali/ali rabbits on OP9 stroma in the presence of IL-7. After 1 week, most of
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the cells (~70-95%) were pro-B and were re-plated on fresh OP9 stroma and allowed to
differentiate in the absence of IL-7 (Fig. 38 and methods). Pro-B, pre-B and immature B
cells were sorted from these cultures and the VDJ genes were PCR-amplified and
sequenced (see methods for sorting details). VDJ gene rearrangements are considered
functional if they lack stop codons and the JH segment is in the preferred reading frame
that encodes a conserved tryptophan-glycine-proline (WGP) sequence following CDR3.
I analyzed non-functional (stop codon or JH-WGP out of frame) VDJ gene
rearrangements of in vitro derived pro-B cells to determine the frequency of VH gene
usage in the absence of selection and found that 14/15 sequences utilized VH4 (Fig. 39).
These data were consistent with previous in vivo reports that VH4 is predominately
rearranged during B cell development in ali/ali rabbits (Fig. 42, left) [298, 307]. Upon
examining the productive (no stop codons, JH-WGP in frame) rearrangements in the
immature B cell compartment, I found the majority of these sequences utilized VHn genes
(Fig. 40) as was found in vivo (Fig. 42, right).
The similarity of VH gene utilization between the in vitro- and in vivo-derived pro-B
and immature B cells demonstrates that the OP9 co-culture system recapitulates ali/ali B
cell development and selection in vivo. However, VH gene usage between in vivo and in
vitro derived pre-B cells differed. In vitro-generated pre-B cells predominantly utilized
VH4 (Fig. 41), whereas in vivo, VHn-genes predominated (Fig. 42, center). Because VH4utilizing pre-B cells are virtually undetectable in vivo and yet are readily detected
in vitro, we hypothesize that in vitro derived VH4-utilizing pre-B cells represent an early
pre-B stage that has not undergone selection. The observed increase in VHn gene usage
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by in vitro derived ali/ali immature B cells confirms that the VH4-utilizing cells are
ultimately selected against in vitro but perhaps with slower kinetics than in vivo.
We hypothesize that VH4-utilizing pre-B cells are selected against either due to failed
expansion or through apoptosis. In either case, the similar VH gene usage between invitro and in vivo derived pro-B and immature B cells demonstrates that selection against
VH4-utilizing cells does not require the rabbit BM environment and suggests a cell
intrinsic mechanism for pre-B cell loss.
VH4-utilizing Pre-B Cell Proliferation In Vitro
In vitro culture of ali/ali rabbit BM yields an enriched population of VH4-utilizing preB cells that likely have not undergone selection, providing us with a system to determine
the mechanism(s) for VH4-utilizing pre-B cell loss. As discussed earlier, the high
frequency of VH4 gene usage by in vitro derived ali/ali pre-B cells suggests that these
cells are an early pre-B cell population that has not yet been selected, as VH4-utilizing
pre-B cells in vivo are not readily detected. During the normal course of B cell
development, early pre-B cells differentiate into proliferating large pre-B cells [30, 308].
To determine if the in vitro-derived ali/ali pre-B cells undergo normal proliferative
expansion, I labeled ali/ali pro-B cells with CFSE and transferred them to fresh OP9
stroma. As a control, I also cultured wt rabbit BM that yields pre-B cells utilizing VH1, a
gene that allows for normal development in vivo, and therefore, should allow for normal
pre-B cell expansion in vitro.
Between days 3 and 6, I found almost no increase in proliferation of ali/ali pre-B cells
relative to pro-B cells, whereas nearly all of the pre-B cells from wt rabbits proliferated
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more than the pro-B cells (Fig. 43). These cultures did not exhibit a large difference in
total number of B-lineage cells (Fig. 44A), but by day 6, the ratio of pre-B to pro-B cells
in the ali/ali cultures was considerably lower than in wt cultures (<1:1 and ~3:1
respectively; Fig. 44B and Fig. 45). Additionally, the B-lineage cells in these cultures did
not display evidence of caspase-3 activation (Fig. 46), suggesting the decrease in pre-B to
pro-B cell ratios in ali/ali cultures is not likely due to increased apoptosis, and we
conclude that VH4-utilizing pre-B cells do not undergo normal proliferative expansion.
Pre-BCR Signaling in VH4-utilizing B-lineage Cells
Proliferation of pre-B cells is tightly linked to pre-BCR formation and signaling.
Studies of mouse μ-chains unable to form or signal through the pre-BCR do not allow for
normal pre-B cell proliferation. We, therefore, hypothesized that the impaired
proliferation of VH4-utilizing pre-B cells is due to decreased pre-BCR signaling (Fig. 47).
Pre-BCR crosslinking initiates a signal cascade similar to the conventional BCR that
includes phosphorylation of Igα/β and spleen tyrosine kinase (Syk), which ultimately
leads to pre-B cell proliferation (Fig. 48A) [283]. I used a cross-reactive antibody that
recognizes rabbit-phospho-Syk (P-Syk) (see materials and methods) to compare the
levels of pre-BCR signaling between in vitro derived ali/ali and wt pre-B cells
(experimental set-up described in Fig. 48B). The P-Syk levels in pro-B cells served as a
negative control since cells lacking µ-chains should not express phosphorylated Syk
[309].
I found consistently higher levels of P-Syk in wt pre-B cells than in ali/ali pre-B cells
(Fig. 49). These data are consistent with the decrease in ali/ali pre-B cell expansion

121

122

123

124
shown in Figure 43, and from these data, we conclude that the impaired proliferation of
ali/ali VH4-utilizing pre-B cells is likely due to insufficient pre-BCR signaling.
Pre-BCR Formation by VH4-μ
The reduction in ali/ali pre-BCR signaling and limited proliferation of ali/ali pre-B
cells led us to hypothesize that VH4-μ chains do not form functional pre-BCR. I tested
this possibility by expressing chimeric rabbit-VDJ murine-Cμ chains in the SLexpressing murine 38B9 pre-B cell line [83]. The μ-chains that pair with SL transit to the
cell surface resulting in surface-μ+ cells, which is suggestive of pre-BCR formation (Fig.
50). Initially, I compared the ability of VH4-µ chains from multiple rabbit tissues (fetal
liver, fetal BM, neonatal spleen) or from in vitro derived ali/ali pre-B cells to pair with
SL. The VH4-μ chains were expressed on the cell surface, suggesting that they do pair
with SL; however, their level of surface-μ expression was consistently lower than VH1-μ,
which allows for normal proliferation (Fig. 51).
I found similar results with several µ-chains from in vitro derived ali/ali pre-B cells
and from ali/ali neonatal spleen (Fig. 52, sequences in Fig. 54). That VH4-μ chains are
not as highly expressed on the cell surface as VH1-μ chains suggests that VH4-μ does not
fold properly and/or fails to pair efficiently with SL. The reduction in VH4 surface-μ
expression was not due to decreased μ protein levels since VH1- and VH4-μ chains were
expressed equivalently in the cytoplasm (Fig. 52, lower). Nor is it likely that the VH1-μ
chain used had unusually high levels of surface-μ expression since multiple VH1- and
VHn-μ chains shared comparable levels of surface-μ expression (Fig. 53 and 52B,
respectively). From these data, we initially concluded that VH4-μ chains do pair with SL
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but with reduced stability and/or efficiency resulting in lower steady state levels of
surface-μ.
Sequence and Structural Parameters that Govern Surface VH4-μ Expression
Remarkably, VH1 and VH4 encode molecules with >90% amino acid identity, and yet
only VH1 confers efficient progression through the pre-B cell stage. VH1 and VH4 differ
by 9 amino acid residues, one of which, the tryptophan at position 47 (W47), is highly
conserved in most VH regions across species (Fig. 55)[297]. Crystal structure analysis
shows an interaction between W47 and the unique region (UR) of λ5 during pre-BCR
formation; however, W47 is not predicted to interact with conventional IgL (Fig. 56)
[249, 310]. VH1 encodes the conserved W47, whereas VH4 encodes a tyrosine (Y47), and
we hypothesized that Y47 interferes with VH4-μ pre-BCR formation since it has replaced
an evolutionarily conserved residue that interacts with SL. Further, we knew that VH4-μ
chains form functional BCR as evidenced by VH4-utilizing B cell expansion in the
periphery; therefore, loss of VH4-utilizing pre-B cells should be pre-BCR specific and not
have an effect on conventional BCR formation. Again, Y47 is a strong candidate because
it could conceivably have deleterious interactions with SL but have no effect on
conventional IgL pairing.
I generated mutant VH4-μ chains by substituting the conserved tryptophan in place of
Y47 (VH4-Y47W). If W47 was sufficient to restore SL pairing, then we expected VH4Y47W μ-chains to have increased levels of surface-μ expression compared to germline
VH4-μ in 38B9 cells (Fig. 57). I found that making the single Y47W substitution in VH4
improved the levels of surface-μ expression and, in some cases, completely restored
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surface-μ levels to that of VH1-μ (Fig. 58). These data indicated that the conserved W47
was sufficient to improve VH4-μ/SL pairing and further suggested that the Y47 encoded
by germline VH4 is problematic for these processes.
VH Mutagenesis to Determine if Y47 Interferes with μ/SL Pairing
The data in Figure 58 showed that by replacing a single amino acid residue in FR2 of
VH4, the level of surface VH4-Y47W-μ expression and presumably SL pairing was
improved. An interesting aspect of this mutation is that tryptophan (W) and tyrosine (Y)
have similar structures, in that they are both bulky aromatic residues; however, the major
difference between these residues is the more stringent requirement for Y to form a
hydrogen bond (Fig. 59). This becomes increasingly important when considering the
structure of the pre-BCR since W47 is not predicted to H-bond with H2O or nearby
amino acids and is located in a region that is not solvent accessible. Y47 is presumably
subjected to the same hydrophobic environment and, therefore, could induce unfavorable
H-bonds with surrounding amino acids or could bring a water molecule into the structure,
both of which may be problematic for μ-folding or SL interaction (Fig. 59).
The hypothesis that the OH group of Y47 is problematic for μ-folding/SL pairing was
tested by mutating VH4-Y47 to phenylalanine (VH4-Y47F). F47 will share the same
hydrophobic and aromatic properties of Y47 but will lack the requirement for H-bonding
(Fig. 59). Therefore, if lower VH4-μ expression on 38B9 cells is due to the OH group of
Y47, then mutating this residue to phenylalanine should improve surface-μ expression
similarly to W47. In contrast to our prediction, I found that the VH4-Y47F mutation had
no effect on surface-μ expression in the 38B9 system (Fig. 60), suggesting that the OH
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group of Y47 may not be inherently problematic to VH-folding/SL pairing and that the
increase in VH4-Y47W surface-μ expression is due to a unique property of tryptophan.
Determining if W47 in VH1-μ is Required for Optimal Surface-μ Expression
VH1-μ chains consistently display higher levels of surface-μ expression than VH4-μ
chains, and making the single Y47W mutation in VH4 improved or fully restored surfaceμ expression on 38B9 cells to that of VH1-μ. To determine if W47 of VH1 is required for
optimal surface-μ expression, I mutated the conserved W47 to tyrosine (VH1-Y47W-μ),
and we predicted that these μ-chains would have lower surface-μ expression than
germline VH1-μ chains. In contrast to our prediction, I observed no difference in surfaceμ expression between VH1-W47Y and germline VH1, indicating that this single amino
acid substitution did not affect μ-chain folding and/or SL chain pairing. This was
puzzling because the complimentary mutation in VH4 (VH4-Y47W) was sufficient to
restore surface-μ expression, and we wondered if additional residues encoded by VH4
were acting in conjunction with Y47 to prevent optimal surface-μ expression. To test this
possibility, I made an additional mutation in VH1 to make it more “VH4-like” and tested
the effects of these mutations on surface-μ expression in 38B9 cells.
Aside from residue 47, there are eight other differing amino acids between VH1 and
VH4 (Fig. 55). I focused on the residue at position 50 (VH1, alanine (A50); VH4,
threonine (T50)) due to its close proximity to residue 47. I modeled a pre-BCR Fab’-like
region that encoded both Y47 and T50 in VH, and found that the side-chains of these
residues were in close proximity (~3 Ǻ) (Fig 62A). This distance is close enough for
steric interactions between the side chains of these residues, not to mention any additional
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H2O molecules that may be forced into this region due to the H-bond requirements of
tyrosine and threonine. Crystal structures only provide snap-shots of dynamic structures
that can, and likely do, oscillate between conformations in solution. Therefore,
generating mutations in known crystal structures is predictive at best, and
experimentation is required to test these predictions.
To determine if Y47 in conjunction with T50 is problematic for μ-folding/SL pairing,
I generated VH1 double mutants (VH1-W47Y+A50T) to make VH1-μ more “VH4-like”.
We predicted that these two mutations together should result in lower surface-μ
expression (Fig. 62B). However, I found that the surface-μ expression between VH1W47Y+A50T and germline VH1 μ-chains was comparable (Fig. 63). These data indicate
that these “VH4-like” mutations in VH1 are not sufficient to lower surface-μ expression.
Therefore, decreased surface-μ expression by VH4-μ is not simply due to the combination
of Y47+T50 residues in FR2 and must require other amino acids in VH or CDR3 and will
be discussed later.
Surface VH4-μ Expression vs. VH4-utilizing Pre-BCR Formation
We interpreted my data from the VH1 and VH4 mutagenesis studies to mean that VH4-μ
could pair with SL, as μ-chains were expressed on the 38B9 cell surface. We further
thought that VH4-μ formed pre-BCR with decreased efficiency or stability resulting in
lower steady state levels of surface-μ compared to VH1-μ chains. The caveat to these
experiments is that I have been using surface-μ expression as an indicator of SL pairing,
which was reasonable based on previous studies using the 38B9 cell line [83] [263, 306,
311]. However, in some instances, surface-μ expression can be observed in the absence

141

142

143
of SL, indicating that surface-μ expression does not always equal surface pre-BCR
expression (Fig. 64) [253].
I can distinguish between surface-μ expression and surface pre-BCR expression in the
38B9 system by using an antibody (SL-156) that only recognizes μ paired with SL
through binding a conformational epitope. I retested nine of the VH4-μ chains for their
capacity to form pre-BCR on the surface of 38B9 cells and found that the majority (8/9)
of VH4-μ chains had undetectable levels of surface pre-BCR, whereas VH1- and VHnutilizing pre-BCR were detected on the cell surface (Fig. 65A and B, upper). The general
inability to detect VH4-utilizing pre-BCR suggests that VH4-μ chains do not pair with SL
and likely travel to the cell surface in a SL independent manner. We also learned that our
initial assumption that surface-μ expression on 38B9 cells correlates with surface preBCR expression was incorrect.
In light of this finding, I retested one of the site-directed mutant VH4-Y47W-μ chains
[(GR39-Y47W) that was shown to restore surface-μ expression (Fig. 58)] for differences
in surface pre-BCR expression. I found that the Y47W mutation had no impact of the
levels of surface pre-BCR expression (Fig. 66), suggesting that the increased surface-μ
observed with VH4-Y47W was likely SL independent. I also retested the “VH4-like”
VH1-μ chains (VH1-W47Y and VH1-W47Y+A50T) for differences in surface pre-BCR
expression and found that these mutations also had no effect, (Fig. 67A and B),
suggesting that Y47 and T50 do not impair pre-BCR formation.
In summary, I found that VH4-μ chains generally do not form detectable surface preBCR on 38B9 cells, whereas VH1- and VHn-μ chains do. Mutation of VH4-Y47 to the
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conserved tryptophan results in increased levels of surface-μ but does not rescue surface
pre-BCR formation (Fig. 68). Likewise, mutating VH1-W47 to tyrosine (or mutating
both W47Y +A50T) was not deleterious to pre-BCR formation suggesting that these
residues alone are not solely responsible for the inability of VH4-μ to form pre-BCR.
These data do not rule out the possibility that other combinations of residues in VH4 or
CDR3 operate in conjunction with Y47 to impair pre-BCR formation. The general
inability of VH4-μ chains to form detectable surface pre-BCR in 38B9 cells correlates
with decreased proliferation and pre-BCR signaling observed in VH4-utilizing pre-B cells
from ali/ali rabbits.
Rescue of VH4-utilizing B cells in Igκ Transgenic Rabbits
While most VH4-utilizing B-lineage cells are lost at the pre-B cell stage, some of these
cells survive development and enter into the periphery as immature B cells. The capacity
of some VH4-utilizing cells to survive the pre-B stage may be attributed to select VH4-μ
chains that can pair with SL and provide sufficient pre-BCR signaling. However, the
inability of most VH4-μ chains from ali/ali neonatal spleen to pair with SL suggests that
there are other mechanisms, independent of SL pairing, by which VH4-utilizing B-lineage
cells survive development. One possibility is that select CDR3 regions stabilize the preBCR or render a signal-competent μ-chain independent of SL. Although these
mechanisms have been described in mouse, they are usually associated with particular
sequence patterns in CDR3 [57, 253, 304-306, 312]. I have sequenced the CDR3 of
several undiversified VH4-DJ genes from ali/ali neonatal spleen, and I do not detect any
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unusual patterns that indicate selection of μ-chains with particular CDR3 sequences (Fig.
69), suggesting that CDR3 may not compensate for presumed structural defects in VH4-μ.
Other studies in mouse have found that a small percentage of developing B cells
rearrange IgL genes prior to IgH genes [251, 252]. We hypothesized that some VH4utilizing B-lineage cells may be rescued by expression of IgL and bypass the need for
pre-BCR signaling in early B cell stages (Fig. 70). I tested this possibility by examining
the peripheral blood B cell compartment of ali/ali rabbits expressing a human Igκ-chain
transgene (Igκ-tg) (see methods for details on transgenesis). If the Igκ-tg rescued VH4utilizing pre-B cells, then we expected to find more VH4-utilizing B cells in the blood of
young (5 wk) Igκ-tg ali/ali rabbits than in age-matched non-transgenic ali/ali rabbits
(Fig. 71). As predicted, I found a doubling of peripheral B cells Igκ-tg ali/ali rabbits (as
measured by % IgM+ cells in the lymphocyte gate, 42% (Igκ-tg) vs. 22% (non-tg)) and a
nearly 3- fold increase in the VHa+ B cell population (utilizing VH4, VH7 or VH9)
compared to age matched non-transgenic ali/ali rabbits (31% vs.12%)(Fig. 72). By
nucleotide sequence analysis, 80% of the VDJ genes in VHa+ B cells from the Igκ-tg
rabbit utilized VH4 (Fig. 73). We conclude that developing B cells utilizing VH4 can be
rescued by conventional Igκ-chain expression, suggesting that IgL expression during B
cell development allows VH4-utilizing B-lineage cells to bypass the pre-B stage.
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CHAPTER FOUR
DISCUSSION
The ali/ali Rabbit: A Novel System to Study Early B cell Development
The ali/ali rabbit provides a model system to study B cell selection in the BM and in
the periphery. The almost complete loss of VH4-utilizing B-lineage cells in the BM of
young ali/ali rabbits gave us an opportunity to discover new mechanisms by which VH
gene usage affects B cell development. In mouse, VH genes that inhibit normal B cell
development are typically associated with defects in both SL and conventional IgL
pairing, leading to the hypothesis that pre-BCR formation and signaling tests the
structural fitness of μ-chains through pairing with SL [224]. Early B cell selection in the
ali/ali rabbit differs from mouse in that VH4-μ chains readily pair with a variety of
conventional IgL chains yet have a block in early B cell development [298]. This
suggests that VH4-μ chains are structurally sound in terms of conventional BCR
formation and that loss of VH4-utilizing B-lineage cells during development is likely
associated with abnormal pre-BCR formation and signaling.
When starting this project, we knew that VH4 was predominantly rearranged during B
cell development in ali/ali rabbits and that most VH4-utilizing cells were lost in the BM
by an unknown mechanism. One possibility was that, similar to mouse, VH4-μ chains
had structural defects that prohibited pre-BCR formation and signaling. An alternative
possibility was that VH4-utilizing cells were deleted due to autoreactivity. If the
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developmental block was due to defects in pre-BCR formation and/or signaling, then we
could utilize the ali/ali rabbit model to identify structural parameters of VH that are
specifically required for SL pairing but dispensable for conventional IgL pairing.
Alternatively, if VH4-utilizing cells were lost during early B cell development due to
autoreactivity, then it would be one of the few examples where the specificity of the
antibody repertoire is shaped prior to the immature B cell stage [261]. In either instance,
the ali/ali system would allow us to learn something novel about the basic science of B
cell development.
The B-lineage cells of wt rabbits predominantly rearrange VH1, which allows for
normal B cell development, and ali/ali B-lineage cells predominantly rearrange VH4,
resulting in a developmental block. The strength of this system is that the proteins
encoded by VH1 and VH4 are >90% identical (Fig. 55) but have strikingly different effects
on B cell development. There are only nine amino acid differences encoded by VH4 and
VH1 that dictate B cell fate during development. In contrast, mouse VH genes that are
problematic for B cell development are, at most, 80% homologous to VH genes allowing
for normal B cell development, making it more difficult to identify potentially inhibitory
amino acid residues [313]. Finally, VH4-μ chains have the capacity to form conventional
BCR suggesting that they do not have gross intrinsic structural defects, whereas VH
regions in mouse that do not pair with SL (e.g. VH81x, VH12) typically also fail to form
conventional BCR [139, 306]. Therefore, studying VH4 in the context of early B cell
development using ali/ali rabbit provided an opportunity to identify structural parameters
of VH required for normal B cell development at the amino acid level.
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The nine amino acid differences between VH1 and VH4 span structural framework
regions (FR1-2) and the antigen binding domain (CDR1) (Fig. 74), indicating that loss of
VH4-utilizing cells could be due to autoreactivity or cell intrinsic mechanisms.
Additionally, CDR3 (encoded by DJH) could work in conjunction with the VH4 region to
prevent normal B cell development (Fig. 74). The following sections discuss my
experimental results regarding the mechanism of VH4-utilizing cell loss during B ell
development in ali/ali rabbits with thoughts on future experiments and mechanisms that
generate the antibody repertoire.
Mechanism for Loss of VH4-utilizing B cells in ali/ali Rabbit BM
VH4-utilizing pre-B cells from ali/ali rabbits do not undergo normal expansion when
cultured in the absence of the rabbit BM environment suggesting a cell intrinsic
mechanism for VH4-utilizing cell loss. The lack of VH4-μ pre-BCR formation and the
decrease in pre-BCR signaling were consistent with diminished VH4-utilizing pre-B cell
proliferation. There was some low level signaling within VH4-utilizing pre-B cells that
might be explained by tonic signals from VH4-μ chains at the cell surface independent of
SL. The decreased VH4-μ signaling also suggests that these cells were not interacting
with components of the stromal environment since autoreactive B cells display high
levels of BCR signaling, which results in apoptosis (or receptor editing) at the immature
B cell stage, whereas strong signals at the pre B cell stage are only associated with
proliferation [33, 88, 89, 309]. Additionally, in vitro culture of ali/ali B-lineage cells did
not exhibit differences in total cell numbers or an increased frequency of apoptosis,
arguing against active deletion of VH4-utilizing pre-B cells. Therefore, the paucity of
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VH4-utilizing pre-B cells in BM of ali/ali rabbits is likely due to deficiencies in pre-BCR
formation/signaling and decreased VH4-utilizing pre-B cell expansion.
Possible Mechanisms for Survival of Select VH4-utilizing B-lineage Cells in BM
Select CDR3 Regions Allow VH4-μ Chains to Form Pre-BCR
VH4-utilizing B cells are detectable at a low frequency in the spleen of neonatal ali/ali
rabbits, and with time, these cells (and other cells encoding the a-allotype) expand in the
periphery. These observations indicate that a mechanism exists to allow some VH4utilizing cells to survive B cell development in BM. One possibility was that select VH4μ chains were able to pair with SL through compensatory properties of CDR3 (encoded
by DJH). This was a reasonable hypothesis since CDR3 has the capacity to form
significant interactions with SL (Fig. 74) and therefore could strengthen pre-BCR
formation. Further, mouse VH regions that generally do not pair with SL can form preBCR when expressing select CDR3, suggesting that this is a viable mechanism for
survival of VH4-utilizing pre-B cells [139, 306].
If compensatory properties of CDR3 allowed VH4-μ chains to form pre-BCR and
undergo normal B cell development, then we expected VH4-μ chains from spleen to form
pre-BCR. This was not the case as several μ-chains obtained from splenic B cells were
unable to pair with SL. Additionally, instances where μ-chain CDR3 rescue SL pairing
in mouse have been associated with specific patterns in the CDR3 amino acid sequence,
and we did not detect any obvious patterns in the CDR3 of VH4-μ chains isolated from
neonatal spleen. This suggested to us that survival of select VH4-utilizing B-lineage cells
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is not likely due to a compensation by CDR3 that enables VH4-μ to form pre-BCR and is
rather due to a SL independent mechanism.
SL Independent Signaling by VH4-μ Chains
The inability of VH4-μ chains from ali/ali pre-B cells to form pre-BCR does not rule
out the possibility that SL-independent signaling by VH4-μ chains mediates early B cell
survival. Consistent with this hypothesis, all VH4-μ chains were expressed on the cell
surface of a pre-B cell line; however, they did not appear as a pre-BCR complex. Signals
from VH4-μ chains in the absence of SL would not be expected to crosslink and signal for
proliferation due to lack of the λ5-UR that mediates pre-BCR homotypic and stromal cell
interactions. SL independent VH4-μ chains could transduce low level tonic signals for
survival, allelic exclusion, and continued differentiation. While this mechanism would
allow for some VH4-utilizing cells to survive development, their inability to expand
would put them at a considerable disadvantage compared to other pre-B cells (e.g. VHnutilizing cells) in the BM that presumably undergo normal pre-BCR induced
proliferation.
An alternative possibility is that conventional IgL expression occurs prior to VH4-μ
expression, allowing for survival signaling through the conventional BCR and bypassing
the pre-B cell stage [251, 252]. Consistent with this hypothesis, expression of an Igκtransgene (Igκ-tg) in ali/ali rabbits rescued the development of VH4-utilizing B-lineage
cells. Although there was a five fold increase in the frequency of VH4-utilizing B cells in
the periphery of Igκ-tg rabbits compared to non-transgenic controls, the percentage of
VH4-utilizing cells in Igκ -tg ali/ali rabbits was lower than we initially expected. We
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thought the frequency of VH4-utilizing cells in the periphery of Igκ-tg rabbits would
reflect that of VH4 gene rearrangement in BM (~80%); however, our observed frequency
of VH4-utilization in the periphery was only 30%, suggesting a partial rescue of VH4utilizing B cell development. The discrepancy between VH4 gene rearrangement in BM
and the frequency of VH4-utilizing B cells in the periphery of Igκ-tg ali/ali rabbits can be
explained by a combination of VH gene rearrangement and signaling differences between
the conventional BCR and pre-BCR as described in the following model.
VHn-μ chains are able to pair with SL, and we hypothesize that VHn-utilizing pre-B
cells undergo normal proliferation downstream of pre-BCR signaling. In contrast, our
data indicate that VH4-utilizing pre-B cells do not undergo normal proliferation due to
their inability to form pre-BCR. These observations explain the abundance of VHnutilizing pre-B and immature B cells in the BM of non-transgenic ali/ali rabbits even
though VH4 is the predominantly rearranged gene. Therefore, the frequency of VH4utilizing cells in the periphery of Igκ-tg ali/ali rabbits will be a combination of VH gene
usage and the degree of expansion by VH4 and VHn-utilizing cells at the pre-B stage. If
VH4-utilizing cells in Igκ-tg ali/ali rabbits only receive survival signals through tonic
BCR (VH4-μ/Igκ-tg) signaling but no proliferation signals from pre-BCR (VH4-μ/SL)
signaling, then the frequency of immature VH4-utilizing cells leaving the BM would only
reflect the frequency of VH4 gene rearrangement. In contrast, if VHn-utilizing cells of
Igκ-tg ali/ali rabbits receive proliferative pre-BCR signals (VHn-μ/SL) in addition to
tonic BCR (VHn-μ/Igκ) signals, then the frequency of immature VHn-utilizing cells will
be a combination of both VHn gene rearrangement and the degree of pre-B cell
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proliferation. If we assume that the ratio of VH4 to VHn rearrangement is 5:1 and that
VHn-utilizing cells undergo four rounds of pre-BCR mediated proliferation (a reasonable
estimate considering murine pre-B cells undergo between 2-6 rounds of division [30]),
then for every five VH4-utilizing cells we would expect sixteen VHn-utilizing cells
(one VHn-utilizing cell undergoing 4 rounds of pre-BCR mediated division) (Fig. 75).
Therefore, the predicted frequency of VH4-utilizing B cells in the periphery of Igκ-tg
ali/ali rabbits is ~30%, which is remarkably similar to our observed frequency.
Since VH4-utilizing B cells are rarely detected in the BM of young ali/ali rabbits, it is
likely that the mechanism(s) allowing for VH4-utilizing cells to bypass the pre-B stage
occurs infrequently, making the low frequency of IgL expression prior to VDJH gene
rearrangement a plausible mechanism by which select VH4-utilizing B cells survive
development. The rescue of VH4-utilizing B cell development through Igκ-tg expression
in ali/ali rabbits reinforces the notion that VH4-μ chains pair with conventional IgL and
that reduced VH4-utilizing pre-B cell expansion results from failure of VH4-μ to form preBCR. We hypothesize that a limited number of VH4-utilizing pre-B cells escape selection
in the BM via SL independent signaling through early formation of the conventional
BCR or through surface VH4-μ expression via an unknown mechanism.
Future Studies Using the ali/ali Rabbit Model System: Identification of Amino Acids
That Prevent VH4-μ/SL Pairing
We have encountered much difficulty trying to identify amino acids encoded by VH4
that are responsible for reduced pre-B cell proliferation and loss of pre-BCR formation. I
was initially drawn to this project by the prospect of identifying the structural parameters
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of VH4-μ that govern pre-B cell development. Having permissive VH1-μ chains with near
identity to non-permissive VH4-μ chains with regards to B cell development, combined
with the crystal structure of the human pre-BCR, provided me with excellent tools to
predict problematic residues for VH4-μ/SL interactions.
The amino acid differences between VH1 and VH4 were individual point mutations
confined to FR1 and FR2 with a consecutive stretch of four amino acids in CDR1 (Fig.
74). I initially identified the differing residues between VH1 and VH4 that were predicted
to interact with SL and found only a single amino acid, residue 47 (VH1-W47; VH4-Y47)
that fit these criteria. The other FR residues were on the opposite face of the molecule
and were not predicted to interact with SL in the crystal structure (Fig. 74). I focused
heavily on residue 47, and multiple substitutions in VH4 (VH4-Y47W, Y47F), did not
restore SL pairing nor did the complementary mutation in VH1 (VH1-W47Y) reduce preBCR formation. These studies suggested that the Y47 encoded by VH4 was insufficient
to explain the impaired pre-BCR formation by VH4-μ chains. The only other FR residue
in the vicinity that may have affected VH4-μ pairing was at position 50 (VH1-A50, VH4T50), and when I made the double mutation in VH1 to make it more “VH4-like” (VH1W47Y+A50T), there was still no difference in SL pairing. These were the most logical
mutations to make based on the sequence data and the fact that these residues were
predicted to interact specifically with SL but not with the conventional IgL (Fig. 56).
The close proximity of CDR1 to Y47 suggests that these residues could work in
conjunction to prevent VH4-μ folding or SL pairing (Fig. 74). Alternatively, the other
differences in FR1 could have distal effects on VH folding or structure that would negate
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SL pairing, although it is hard to conceive of a general folding defect in VH4-μ that only
affects SL pairing with no effect on IgL pairing. Close analysis of VL gene usage in VH4utilizing B cells that survive development may reveal characteristic VJL rearrangements
that are required for conventional BCR formation by VH4-μ. Special compensations by
VL may induce the correct folding of VH4-μ by a mechanism that is unfeasible for SL.
The CDR1 regions may also interact with the URs of Vpre-B or λ5 in a way that was
unpredictable based on current crystal structure data. The URs are stretches of amino
acids (VpreB-UR ~30 residues and λ5-UR ~60 residues) that are highly disordered and
have not been crystallized [44, 45]. It is possible that one or both of these URs interact
with distal portions of FR1 or CDR1 of VH4-μ and inhibit pre-BCR formation. To test
this possibility, I would propose systematically exchanging complete FR1, CDR1, and
FR2 sequences between VH1 and VH4 and determine which region(s) are problematic for
SL pairing. From there, one could perform site-directed mutagenesis to determine which
residue(s) are required for normal pre-BCR formation.
Ideally, future experiments to determine the mechanism by which VH4-μ is unable to
pair with SL would use an all rabbit model system. If possible, a rabbit pro-B cell line
that expressed the SL but lacked endogenous-μ would be used to test pre-BCR formation
by VH1- and VH4-μ chains. The Vpre-B and λ5 of mouse and rabbit share 70% and 57%
identity, respectively [151]. We thought using a mouse pre-B cell line for our studies of
rabbit VH4-μ was reasonable since both VH1- and VHn-μ chains paired with mouse SL;
however, we cannot rule out the possibility that VH4-μ pairing with rabbit SL would be
different than what we observed in the mouse system. Perhaps expressing the VH4-
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Y47W-μ chain in an all rabbit system would be sufficient to restore pre-BCR formation.
I attempted to address pre-BCR formation using rabbit VH4-μ and rabbit-SL through
overexpression studies using insect and 293T-cells; however, I encountered difficulty in
expressing epitope tagged versions of rabbit SL. Therefore, directly investigating the
ability of VH4-μ chains to pair with rabbit SL would work best in a rabbit pro-B cell line
expressing the native forms of Vpre-B and λ5. I am still very excited about the
possibility that the ali/ali model system can be further developed to identify specific
differences between VH1- and VH4-μ which explain the observed deficiency in VH4-μ
pairing with SL.
Hypothetical Studies Using Genetically Engineered wt and ali/ali Rabbits
Rabbits are not as genetically tractable as mice, mainly due to the difficulty of keeping
inbred rabbit strains. Our lab and others have generated some transgenic and knockout
rabbit lines and the technology continues to evolve [149, 314] [315, 316]. In this section,
I will propose some hypothetical studies that would require genetically engineered
rabbits, and perhaps in time, these experiments can be attempted.
Targeted Gene Deletion Using Zinc Finger Nucleases (ZFN)
Zinc finger nucleases (ZFN) are useful for gene ablation in the germ cells of species
for which embryonic stem cell cultures are not established. ZFN technology works by
inducing double stranded DNA breaks in the coding regions of target genes [317]. The
specificity of the ZFN is dictated by tandem zinc finger motifs that individually recognize
six base pair stretches, but in combination can specifically recognize unique stretches of
DNA. The zinc finger domains are attached to the Fok-1 endonuclease that induces DNA
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cleavage. Two ZFN constructs are designed to flank the target site of DNA cleavage and
are microinjected into a newly fertilized oocyte. The ZFN proteins will enter the nucleus
and induce double stranded DNA breaks upon binding their target sequence [316].
Permanent gene ablation occurs via low fidelity mechanisms that repair dsDNA
breaks through introduction of base pair deletions or insertions that shift the coding
region out-of-frame [318]. If the deletion occurs in the germline, then the null allele can
be passed on to subsequent generations. ZFNs can also generate knock-in animals
through a similar process to gene deletion, except that a segment of DNA with
homologus ends to the target site of the double stranded break is co-introduced with the
ZFN to recombine with the target DNA sequence [317, 318].
Successful gene ablation occurs in 20-30% of fertilized oocytes and gene knock-in
occurs at a frequency of ~2-5% [316]. The key to this technology is to engineer the
correct sequence of tandem zinc finger motifs that ensure high specificity of the nuclease
for the gene of interest. Some websites have developed algorithms to assist in ZFN
design (e.g. http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx), and this technology has
recently been used in rabbit to ablate IgM function [316]. Described below are
hypothetical rabbit knockout strains that would be useful for addressing future questions
regarding B cell development and selection in ali/ali and could theoretically be generated
using ZFN technology.
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Generation of VH1 rabbits
The ali/ali rabbit is a naturally occurring mutant that was discovered amongst a
wildtype population. It is technically a VH1null/null rabbit due to a 10 kb deletion in the
IgH locus that encompasses VH1 and is not a true VH1 knockout rabbit [16]. Our data
suggest that the low frequency of VHa+ B cells in the periphery of young ali/ali rabbits is
explained by the deletion of VH1, although we cannot rule out the possibility that the
ali/ali phenotype is partially due to other factors in the 10 kb deletion or perhaps
alterations elsewhere in the ali/ali genome. To address this possibility, I propose
generating a targeted VH1 gene deletion in wt rabbits, and I predict that this deletion
would be sufficient to recapitulate the ali/ali phenotype.
Generation of VH1-/- VH4-/- Double Knockout Rabbits
VH1 is the 3’ most functional VH gene in wt rabbits and is utilized in the majority of
VDJ gene rearrangements during B cell development. The mechanism for the bias in
VH1 gene usage in rabbit is still not understood. In ali/ali rabbits, VH1 is deleted and by
default VH4 becomes the 3’ most functional VH gene, and it is utilized in the majority of
VDJ gene rearrangements during ali/ali B cell development [307]. This suggests that the
bias in VH1 usage during wt rabbit B cell development may not reflect a special property
of VH1 other than it being the DH proximal VH gene. It would be interesting to assess VH
gene usage in a VH1-/- VH4-/- double knockout rabbit. I would predict that in the absence
of VH1 and VH4, the next most functional VH gene, VH7, would be utilized in the majority
of Ig gene rearrangements. VH7, like VH1 and VH4, encodes the a-allotype, and if VH7
was predominantly rearranged and allowed for normal B cell development, then I would
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expect the peripheral VHa B cell population to be indistinguishable from wt rabbits
(~80% VHa+). However, if VH7 is also problematic for early B cell development, then it
would suggest that VH1 has been selected as the predominantly rearranged VH gene due
to properties that extend beyond its being the 3’ most VH gene in wt rabbits.
If VH7 was utilized in most rearrangements and allowed for normal B cell
development, then it could provide important information regarding the loss of VH4utilizing cells since VH7 is ~80% identical to VH4 and VH1. Although VH1, VH4, and VH7
share a high level of amino acid identity, most of the differing residues are not shared by
all three VH regions. If VH7 allowed for normal B cell development, then there would
only be four unique residues encoded by VH4 that differ in both VH1 and VH7. Two of
these residues (Y47 and T50) I have already mutated and found no effect on VH4-μ preBCR formation (Fig. 76), and the other two residues are in CDR1. If VH7 allowed for
normal B cell development, then it would be particularly interesting to proceed with
mutagenesis of the VH4-CDR1 region alone or in conjunction with the previously
mutated residues (Y47 and T50) to determine if these mutations can restore SL pairing.
Upon identifying mutations in VH4 that allow for normal SL pairing, the ultimate
experiment would be to generate a transgenic (ideally a knock-in) ali/ali rabbit bearing a
pre-BCR competent VH4 gene (that I will simply refer to as “modified” VH4), and
determine if it is sufficient to restore VH4-utilizing B cell development. The knock-in
ali/ali rabbit is preferable to allow the “modified” VH4 gene to rearrange with
endogenous DJH regions allowing for a variety of CDR3 and a more physiologically
relevant model of B cell development. If the block in VH4-utilizing pre-B cell
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development in ali/ali rabbits is due to the inability of VH4-μ chains to form pre-BCR and
signal for proliferation, then I would predict that expression of “modified” VH4-μ chains
that can pair with SL should restore normal B cell development.
Would ali/ali Rabbits Survive in the Wild? Drawbacks to Limited VH Gene Usage
Since nearly all pro-B cells in ali/ali rabbits rearrange the VH4 gene that prohibits
normal pre-BCR signaling/expansion, we wondered what advantage is provided by
limited VH gene rearrangement? For rabbits, and other GALT species, the limited
diversity of the antibody repertoire due to restricted VH gene rearrangement is overcome
by mechanisms of B cell diversification in GALT [154-157, 319]. Gene conversion and
somatic hypermutation in GALT continually transform an initially narrow B cell
repertoire into one that recognizes a broad range of antigens with extremely high affinity
[154, 155].
The mechanisms that provide rabbit with high affinity antibodies require an initial B
cell population emanating from the BM [152]. If the single VH gene utilized during
development is deleterious at the pre-B cell stage, then the initial seeding of GALT may
be lagging or absent and could lead to an immunocompromised state early in life. The
ali/ali rabbit is a spontaneous mutant discovered in a laboratory setting and it is possible
that the decreased peripheral B cell population early in life could increase ali/ali disease
susceptibility if these rabbits were in the wild. It is possible that the developmental
processes involving lifelong B-lymphopoiesis with random rearrangement of VDJ genes
has evolved in humans and mice to avoid such a predicament. There are biases in usage
of VH gene families in mouse and human but not specified toward a single VH gene as in
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rabbits. Therefore, defects in particular VH genes would likely not result in a noticeable
block during early B cell development.
While random VH gene usage relieves the pressure on a single VH gene to allow all B
cells to develop normally, it also comes with some disadvantages, including inefficient
generation of B cells. Only a small fraction (~10%) of developing B cells in mouse
survive development in the BM. This may not be so surprising as ~50% of newly made
μ-chains are incapable of forming a pre-BCR, highlighting the inefficient nature of
random V(D)J gene rearrangement during B cell development. The strategy for chicken
B lymphopoiesis is even more restricted than rabbit regarding IgH and IgL gene
rearrangement, with a single functional rearrangement occurring at the IgL locus and
limited rearrangement at IgH due to single VH and JH genes and limited DH gene
segments [156]. The limited use of VDJ genes in chicken allows B cell development to
occur independently of the SL or a pre-B cell stage. The IgH and IgL loci in chicken
rearrange simultaneously, and while their frequency of inframe VDJ gene rearrangements
is not higher than that of other species, the limited Ig gene usage increases the likelihood
that the expressed IgH and IgL chains will form functional BCR [156]. The remaining
VH genes are pseudogenes that, similarly to rabbit, are used for gene conversion in GALT
to generate a diverse primary B cell repertoire [156].
Perhaps the ideal situation for generating the primary B cell repertoire would be a
combination of developmental schemes used by GALT and non-GALT species. Utilizing
multiple VH genes during early B cell development would prevent major blocks in the
BM (as observed in ali/ali rabbits) and allow for efficient seeding of the periphery even if
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utilization of certain VH genes was deleterious. GALT would then serve as a site for
continued B cell expansion and BCR diversification through somatic hypermutation and
gene conversion. In wt rabbits, the bias toward VH1-utilization during B cell
development likely relieves the pressure on VH4-μ to form pre-BCR. We therefore
hypothesize that VH4, as well as VH7, VH9 and pseudo VH genes, have been maintained in
the rabbit Ig locus to serve as nucleotide sequence donors during gene conversion in
GALT.
Model for B cell Selection in the BM and Periphery of ali/ali Rabbits
My dissertation work has addressed the mechanism for loss of VH4-utilizing B-lineage
cells during early B cell development. Previous studies demonstrated that VH4 is the
predominantly rearranged VH gene during B lymphopoiesis in the ali/ali rabbit, however
most of these cells were lost early in development. My data are consistent with a model
in which preferential VH4 gene rearrangement and cell loss occur by a cell intrinsic
mechanism in which VH4-utilizing cells fail to expand at the early pre-B cell stage
(Fig. 77). Normal pre-B cell expansion by cells utilizing the less frequently rearranged
VHn genes likely explains the abundance of VHn-utilizing immature B cells exiting the
BM and entering the periphery. Some VH4-utilizing B cells are able to survive
development in the BM through SL independent mechanisms and enter into the
periphery. These VH4-utilizing cells, and other VHa+ cells, migrate to GALT and are
preferentially expanded through mechanisms that require the intestinal microbiota.
Current studies in our lab are focused on understanding the mechanisms by which the
intestinal microbiota drives the expansion and diversification of VHa+ B cells in GALT.
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